Wyeth

Jun 18, 09
	NEW STORY
09:00 ET	Wyeth Files Definitive Proxy Statement and Announces Date for Annual Meeting of Stockholders
Jun 16, 09
11:51 ET	Wyeth Announces Holder Right to Surrender Convertible Debentures
Jun 11, 09
16:01 ET	Wyeth Declares Common Stock Dividend
07:00 ET	New Phase 3 Data Continue to Indicate that Wyeth's Investigational 13-valent Vaccine Has the Potential to Broaden Coverage Against Pneumococcal Disease
Jun 10, 09
09:40 ET	Wyeth Sets Webcast and Conference Call For 2009 Second Quarter Earnings
May 30, 09
09:00 ET	Wyeth Donates $100,000 to ASCO Cancer Foundation(R) to Support Cancer Prevention and Care
May 29, 09
08:00 ET	New Preliminary Data from Two Studies Show Clinical Activity of Neratinib in Combination with Trastuzumab and in Combination with Paclitaxel in Advanced HER-2 Positive Breast Cancer
May 07, 09
08:00 ET	FDA Grants Priority Review Status to Prevnar 13 Marketing Application
Apr 29, 09
07:00 ET	Wyeth Reports Earnings Results for the 2009 First Quarter
Apr 27, 09
09:00 ET	Wyeth's CONBRIZA Approved in the European Union for Treatment of Postmenopausal Osteoporosis in Women at Increased Risk of Fracture
Apr 23, 09
14:40 ET	Wyeth Announces Full Redemption of $2 Convertible Preferred Stock
12:47 ET	Wyeth Declares Common and Preferred Stock Dividends
Apr 17, 09
09:00 ET	New Partnerships Added to World Federation of Hemophilia Twinning Program
Mar 31, 09
09:30 ET	Wyeth Submits Marketing Application to FDA for its 13-Valent Vaccine for the Prevention of Pneumococcal Disease in Infants and Toddlers
Mar 24, 09
12:06 ET	FDA Approves New Indication for Wyeth's TYGACIL (tigecycline) for the Treatment of Adult Patients with Community-Acquired Bacterial Pneumonia
Mar 20, 09
13:52 ET	Wyeth Sets Webcast and Conference Call for 2009 First Quarter Earnings
Mar 12, 09
16:49 ET	Wyeth to Present at the SG Cowen & Co. 29th Annual Healthcare Conference
Mar 04, 09
14:23 ET	Wyeth Comments on U.S. Supreme Court Ruling in Levine Preemption Case
Feb 19, 09
15:55 ET	CONBRIZA Receives Positive CHMP Opinion for the Treatment of Postmenopausal Osteoporosis in Women at Increased Risk of Fracture
Jan 26, 09
06:51 ET	Wyeth Reports Earnings Results for the 2008 Full Year and Fourth Quarter
Jan 22, 09
17:41 ET	Wyeth Declares Common and Preferred Stock Dividends
Jan 12, 09
08:00 ET	Wyeth Pharmaceuticals and Santaris Pharma Announce Strategic Alliance to Develop RNA-based Medicines
Jan 08, 09
14:30 ET	Wyeth to Present at the JP Morgan Healthcare Conference
Jan 05, 09
10:32 ET	Wyeth to Present at the Goldman Sachs Healthcare CEOs Unscripted Conference
Dec 18, 08
07:12 ET	Wyeth Pharmaceuticals Acquires Thiakis Limited
Dec 12, 08
12:00 ET	Wyeth Announces Positive Data from Phase 2 Study of Neratinib in Advanced HER-2-Positive Breast Cancer
Dec 09, 08
09:27 ET	Wyeth Sets Webcast and Conference Call for 2008 Fourth Quarter and Full Year Earnings
Dec 03, 08
08:31 ET	Wyeth Submits European Marketing Authorization Application for its 13-Valent Vaccine for the Prevention of Pneumococcal Disease in Infants and Young Children
Nov 20, 08
17:20 ET	Wyeth Names Michael Kamarck President, Technical Operations & Product Supply
16:41 ET	Wyeth Declares Preferred Stock Dividend
Nov 13, 08
10:02 ET	FDA Approves Low-dose Regimen of PREMARIN Vaginal Cream to Treat Moderate to Severe Postmenopausal Dyspareunia - Painful Sexual Intercourse
Nov 10, 08
13:48 ET	Wyeth to Present at the Credit Suisse Healthcare Conference
Oct 27, 08
11:16 ET	Phase 3 Data Indicate Investigational 13-valent Vaccine May Broaden Protection Against Pneumoccocal Disease in Children Younger than Two
Oct 22, 08
15:25 ET	New Jersey Diet Drug Trial Completed
07:00 ET	Wyeth Reports Earnings Results for the 2008 Third Quarter and First Nine Months
Oct 15, 08
08:30 ET	Wyeth Provides Regulatory Update Regarding Desvenlafaxine for the Treatment of Major Depressive Disorder
Oct 10, 08
14:30 ET	Wyeth Wins Philadelphia Diet Drug Trial Involving Claim of PPH
Sep 25, 08
18:01 ET	Wyeth Announces Increase in Common Stock Dividend
08:30 ET	Retrospective Analysis of Phase 3 Data Suggest Wyeth's Investigational Compound Bazedoxifene/Conjugated Estrogens Comparable to Placebo on Incidence of Abnormal Mammograms
Sep 23, 08
14:00 ET	Wyeth Selected for 11th Consecutive Year as One of Working Mother Magazine's 100 Best Companies for Working Mothers
08:01 ET	Major Adult Vaccine Clinical Trial for Pneumonia Prevention Begins
Sep 15, 08
10:26 ET	South Africa Begins Introduction of PREVENAR into Childhood Immunization Program
Sep 08, 08
16:05 ET	New Recombinant XYNTHA Now Available for Patients with Hemophilia A
10:13 ET	Wyeth Sets Webcast And Conference Call for 2008 Third Quarter Earnings
Sep 03, 08
15:14 ET	Wyeth Names Daniel J. McIntyre Vice President, Corporate Communications
Aug 11, 08
16:00 ET	Fort Dodge Animal Health Announces Leptoinfo.com Now Available to Dog Owners
Jul 23, 08
07:00 ET	Wyeth Reports Earnings Results for the 2008 Second Quarter and First Half and Raises Earnings Guidance
Jul 21, 08
09:23 ET	Wyeth Pearl River Facility Earns OSHA VPP Star; 2,000th Workplace Recognized in U.S.
Jul 16, 08
16:30 ET	Wyeth and Impax Announce Final Settlement of Effexor XR Patent Suit
Jul 15, 08
10:30 ET	Wyeth Consumer Healthcare Signs Agreement to Purchase ThermaCare from Procter & Gamble
Jul 14, 08
13:47 ET	Two New Jersey Hormone Therapy Lawsuits Dismissed
Jul 09, 08
15:14 ET	Wyeth's Motion to Overturn Punitive Damages Award Granted by Arkansas Court
Jun 30, 08
12:02 ET	Wyeth Sets Webcast and Conference Call for 2008 Second Quarter Earnings
Jun 27, 08
09:30 ET	Wyeth Announces Bernard Poussot Assumes Chairman of the Board Position
Jun 26, 08
15:57 ET	Wyeth Declares Common and Preferred Stock Dividends
10:00 ET	Wyeth Pharmaceuticals Announces Organizational Change
Jun 09, 08
12:30 ET	Wyeth to Present at the Goldman Sachs Annual Global Healthcare Conference
Jun 05, 08
13:00 ET	Fort Dodge Animal Health Announces Reintroduction of ProHeart 6 to the U.S. Veterinary Market
May 31, 08
08:40 ET	New Analyses Presented at ASCO Reaffirmed Efficacy and Safety of TORISEL in Patients With Advanced Kidney Cancer
08:00 ET	New Data Show TORISEL Improves Progression-Free Survival for Patients With Relapsed/Refractory Mantle Cell Lymphoma
May 30, 08
14:00 ET	Wyeth Initiates INTORACT -- A New Clinical Trial to Examine TORISEL Plus Avastin for First-Line Treatment of Advanced Kidney Cancer
May 29, 08
11:16 ET	Wyeth Receives Approvable Letter from FDA for TYGACIL for the Treatment of Patients with Community-Acquired Pneumonia
08:49 ET	Wyeth Receives FDA Fast Track Designation for its 13-valent Pneumococcal Conjugate Vaccine for Infants and Toddlers
May 28, 08
17:15 ET	New England Journal of Medicine Publishes Results From a RELISTOR Phase 3 Clinical Study
May 23, 08
07:00 ET	Wyeth Receives Approvable Letter From FDA for Bazedoxifene for the Treatment of Postmenopausal Osteoporosis
May 22, 08
10:20 ET	Wyeth and Progenics Announce Preliminary Clinical Trial Results for RELISTOR Oral and Intravenous Formulations
May 16, 08
12:15 ET	Wyeth to Present at the 2008 Citi Investment Research Global Healthcare Conference
May 15, 08
10:24 ET	Wyeth's Pristiq, a New Treatment for Major Depressive Disorder in Adults, Now Available in U.S. Pharmacies
Apr 30, 08
14:42 ET	Wyeth Research Head Robert R. Ruffolo, Jr., Ph.D., Announces Retirement
08:33 ET	Wyeth to Present at the Morgan Stanley Global Healthcare Unplugged Conference
Apr 24, 08
17:05 ET	Wyeth Chairman Robert Essner Announces June 27 Retirement
15:35 ET	Wyeth and Progenics Receive Positive Opinion From European Committee for RELISTOR for the Treatment of Opioid-Induced Constipation in Advanced-Illness Patients
14:08 ET	Wyeth Holds Annual Meeting of Stockholders
Apr 23, 08
17:10 ET	More Clinical Data Required to Support European Approval of CAP Indication for TYGACIL
Apr 22, 08
07:00 ET	Wyeth Reports Earnings Results for the 2008 First Quarter
Apr 11, 08
08:54 ET	Wyeth Announces Webcast for Annual Meeting of Stockholders
Apr 07, 08
03:00 ET	Wyeth to Expand State-of-the-Art Nutritional Manufacturing Facility in Singapore
Mar 20, 08
09:57 ET	Fort Dodge's 'Mosquito Shot' Offers Convenient Protection Against Dangerous Mosquito-Borne Illnesses
Mar 14, 08
11:40 ET	Wyeth to Present at the Lehman Brothers Eleventh Annual Global Healthcare Conference
Mar 12, 08
03:00 ET	More Clinical Data Required to Support European Approval of Desvenlafaxine as a Potential Treatment for Vasomotor Symptoms
Mar 11, 08
10:21 ET	Wyeth Sets Webcast And Conference Call For 2008 First Quarter Earnings
Mar 10, 08
06:05 ET	Wyeth to Invest $280 Million to Build State-of-the-Art Nutritional Manufacturing Facility in China
Mar 06, 08
16:34 ET	Wyeth To Appeal Arkansas Hormone Therapy Trial Verdicts
Mar 04, 08
16:03 ET	WHI Findings Published in JAMA Do Not Affect Clinical Guidance for the Appropriate Use of Hormone Therapy
Feb 29, 08
19:24 ET	FDA Approves PRISTIQ(TM) for the Treatment of Adult Patients with Major Depressive Disorder
02:00 ET	Wyeth Pharmaceuticals Ends Collaboration Agreements with Solvay Pharmaceuticals for Bifeprunox and Other Compounds
Feb 28, 08
15:50 ET	Wyeth Announces Executive Change in Finance Organization
Feb 21, 08
19:31 ET	Wyeth's XYNTHA Approved by FDA for Treatment of Hemophilia A
Feb 19, 08
13:15 ET	Wyeth Wins Thimerosal-Autism Case in Maryland Court
Feb 15, 08
15:56 ET	Wyeth Consumer Healthcare Names New Head of Global R&D
Feb 05, 08
16:55 ET	Wyeth Announces Election of Timothy P. Cost as Senior Vice President, Corporate Affairs
Feb 04, 08
11:11 ET	Wyeth to Present at the Merrill Lynch 2008 Global Pharmaceutical, Biotechnology and Medical Device Conference
Jan 31, 08
07:00 ET	Wyeth Reports Earnings Results for the 2007 Fourth Quarter and Full Year
Jan 29, 08
16:46 ET	Wyeth Announces Launch of Own Generic Version of PROTONIX
Jan 28, 08
11:00 ET	Fort Dodge Animal Health and the American Association of Equine Practitioners Launch Educational Web Site
Jan 25, 08
10:04 ET	Wyeth Declares Common and Preferred Stock Dividends
Jan 21, 08
18:50 ET	Wyeth and Teva Pharmaceuticals Extend the Standstill Period Relating to Teva's Launch of Generic Pantoprazole
Jan 17, 08
15:41 ET	Wyeth Consumer Healthcare Supports U.S. Food and Drug Administration Decision for Over-the-Counter Cough and Cold Medications in Children under Two Years of Age
Jan 14, 08
11:04 ET	Thimerosal-Autism Link Rejected by Maryland Court
Jan 03, 08
13:42 ET	Wyeth to Present at the JP Morgan Healthcare Conference
Dec 24, 07
07:05 ET	Wyeth Receives Approvable Letter from FDA for Bazedoxifene for the Prevention of Postmenopausal Osteoporosis
07:00 ET	Wyeth Will Pursue Claim for Damages Resulting From Teva Pharmaceuticals' Launch of Generic Pantoprazole in Violation of PROTONIX Patent
Dec 18, 07
09:58 ET	Wyeth's North Carolina Facilities Recognized as Leaders in Employee Protection and Safety by the North Carolina Department of Labor
Dec 14, 07
16:15 ET	Wyeth Provides Update on Regulatory Review of Viviant (bazedoxifene)
11:19 ET	Wyeth Sets Webcast and Conference Call for 2007 Fourth Quarter and Full Year Earnings
Dec 12, 07
09:08 ET	New Phase 3 Data Showed PRISTIQ Significantly Reduced Symptoms of Major Depressive Disorder Versus Placebo
Dec 05, 07
16:33 ET	Wyeth Receives Honors at the 2007 Scrip Awards
Nov 30, 07
11:00 ET	Wyeth Announces Executive Promotions
Nov 26, 07
15:40 ET	Wyeth's TORISEL Receives European Commission Approval for the Treatment of Advanced Kidney Cancer
Nov 15, 07
17:51 ET	Wyeth Receives FDA Approval of Protonix for Delayed-Release Oral Suspension
13:50 ET	Wyeth Announces Election of New Principal Corporate Officer
13:27 ET	Wyeth Declares Preferred Stock Dividend
Nov 08, 07
13:00 ET	Wyeth to Present at the Credit Suisse First Boston Healthcare Conference
08:30 ET	Wyeth Scientists Receive 2007 Thomas Alva Edison Patent Award
Oct 31, 07
11:40 ET	Wyeth Consumer Healthcare Announces the Availability of Centrum Cardio and New Formula Centrum Products
Oct 30, 07
10:40 ET	Minnesota Hormone Therapy Lawsuit Dismissed
Oct 29, 07
13:00 ET	Wyeth Consumer Healthcare Initiates Voluntary Recall and Replacement Program for Several Robitussin Products and Children's Dimetapp Cold & Chest Congestion
Oct 24, 07
09:16 ET	FDA Accepts Wyeth's Supplemental New Drug Application for Tygacil for the Treatment of Patients with Community-Acquired Pneumonia
Oct 18, 07
06:30 ET	Wyeth Reports Earnings Results for the 2007 Third Quarter and First Nine Months
Oct 15, 07
17:06 ET	Wyeth to Appeal Nevada Hormone Therapy Trial Verdict
09:30 ET	Study Data Results Showed Desvenlafaxine Significantly Reduced Moderate to Severe Vasomotor Symptoms in Menopausal Women Versus Placebo
Oct 05, 07
17:01 ET	Wyeth Presents New Phase 3 Data and Updates Regulatory Timing for NDA Filing of Bazedoxifene/Conjugated Estrogens
04:30 ET	Wyeth Pharmaceuticals Acquires Haptogen Ltd. to Boost Biotechnology Drug Discovery
Oct 04, 07
07:00 ET	Wyeth Comments on PREVNAR and Trends in Pneumococcal Disease
Sep 27, 07
14:51 ET	Wyeth Announces Election of Bernard Poussot as CEO of Company Effective January 1, 2008
14:50 ET	Wyeth Announces the Election of Robert M. Amen to Its Board of Directors
14:49 ET	Wyeth Announces $5 Billion Share Repurchase Program; Declares Increase in Common Stock Dividend
Sep 25, 07
08:00 ET	Wyeth Selected for 10th Consecutive Year as One of Working Mother Magazine's 100 Best Companies for Working Mothers
Sep 24, 07
08:06 ET	Wyeth's Pearl River, N.Y. Facility Celebrates 100 Years of Achievements in Health care
Sep 20, 07
13:29 ET	European Committee Issues Positive Opinion on Wyeth's TORISEL(TM) for Advanced Renal Cell Carcinoma
Sep 19, 07
18:15 ET	Wyeth Presents Phase 3 Fracture Data for Bazedoxifene, an Investigational Therapy for Osteoporosis
Sep 18, 07
09:00 ET	Wyeth to Present at the UBS Global Life Sciences Conference
Sep 07, 07
10:00 ET	Wyeth Sets Webcast and Conference Call for 2007 Third Quarter Earnings
Sep 06, 07
20:11 ET	Wyeth and Nycomed Announce Court Denial of Preliminary Injunction
Sep 05, 07
08:36 ET	Wyeth to Present at the Bear Stearns 20th Annual Healthcare Conference
Aug 20, 07
07:56 ET	Four Wyeth Researchers Honored by American Chemical Society for Pioneering Contributions to Medicinal Chemistry
Aug 13, 07
16:12 ET	EPA Approves Fort Dodge Animal Health's ProMeris for Dogs
Aug 10, 07
08:33 ET	Wyeth to Hold Conference Call and Webcast to Provide Bifeprunox Update
08:30 ET	Wyeth Pharmaceuticals and Solvay Pharmaceuticals, Inc. Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
Aug 09, 07
10:01 ET	Wyeth Rated Best in Pharmaceutical Industry on The Wall Street Journal Patent Scorecard
Jul 31, 07
19:52 ET	Court Takes Matter of Wyeth's Motion for Preliminary Injunction Under Advisement; Obtains Agreement from Teva and Sun to Delay Any Potential Launch of Generic Pantoprazole
16:05 ET	Wyeth Sets Conference Call and Webcast to Provide Pristiq Update
Jul 30, 07
00:01 ET	Lybrel, First Low Dose Combination Oral Contraceptive with Unique 365-Day Dosing, Now Available in U.S.
Jul 27, 07
11:37 ET	Wyeth Team Recognized by White House With Prestigious National Medal of Technology for PREVNAR Vaccine
Jul 24, 07
07:30 ET	Wyeth Receives Approvable Letter from FDA for PRISTIQ for the Treatment of Vasomotor Symptoms Associated with Menopause
Jul 23, 07
11:06 ET	Emerging Feline Disease Causes Tragic Loss for Cat Owner
Jul 20, 07
17:41 ET	Wyeth Wins St. Louis Diet Drug Case
Jul 19, 07
07:00 ET	Wyeth Reports Earnings Results for the 2007 Second Quarter and First Half
Jul 03, 07
02:00 ET	Wyeth Begins Marketing and Distributing BeneFIX in Europe
Jun 29, 07
09:03 ET	Wyeth Announces Election of Mary Katherine Wold as Senior Vice President, Finance
Jun 28, 07
15:53 ET	Wyeth Announces Election of Greg Norden as Chief Financial Officer
14:15 ET	Wyeth Declares Common and Preferred Stock Dividends
Jun 21, 07
14:00 ET	Wyeth Pharmaceuticals Introduces Its First Training Kit to Help People With Hemophilia Learn Self-Infusion Techniques
Jun 20, 07
17:01 ET	New WHI Data Show That Women Aged 50-59 Taking Oral Estrogen Therapy Had Reduced Levels of Coronary Artery Calcification -- a Predictor of Cardiovascular Events
14:30 ET	Wyeth Responds to Verdict in Diet Drug Case
Jun 11, 07
13:51 ET	Wyeth Sets Webcast and Conference Call for 2007 Second Quarter Earnings
Jun 08, 07
08:18 ET	Wyeth to Present at the Goldman Sachs Twenty-Eighth Annual Global Healthcare Conference
Jun 02, 07
09:00 ET	Data Presented at ASCO Showed TORISEL Significantly Increased Quality-Adjusted Survival for Patients With Advanced Renal Cell Carcinoma
May 31, 07
08:19 ET	Philadelphia Hormone Therapy Verdict Overturned in Favor of Wyeth
May 30, 07
21:46 ET	FDA Approves TORISEL, a Targeted First-in-Class mTOR Inhibitor for the Treatment of Advanced Kidney Cancer
18:08 ET	Data Published in the New England Journal of Medicine Showed TORISEL Extended Median Overall Survival for Patients with Advanced Renal Cell Carcinoma
May 24, 07
16:45 ET	Wyeth to Present at the Bank of America Health Care Conference
May 22, 07
19:29 ET	FDA Approves Lybrel, First Low Dose Combination Oral Contraceptive Offering Women the Opportunity to Be Period-Free Over Time
17:00 ET	New Long-Term Data Analyses for Bifeprunox Show Favorable Effects vs. Placebo in Stabilized Patients with Schizophrenia
May 21, 07
18:02 ET	Pooled Studies Showed Desvenlafaxine Succinate Significantly Improved Painful Symptoms and Anxious Symptoms Associated with Major Depressive Disorder in Adults, Compared With Placebo
18:01 ET	New Study Results Provide Additional Data about Short- and Long-Term Use of Desvenlafaxine Succinate in the Treatment of Adults with Major Depressive Disorder
May 18, 07
03:00 ET	Data Show ENBREL Significantly Improved Nail Psoriasis in Patients with Moderate to Severe Plaque Psoriasis
May 15, 07
17:56 ET	Wyeth Wins Philadelphia Hormone Therapy Trial
15:40 ET	Wyeth to Present at the Citigroup Health Care Conference
May 14, 07
05:00 ET	Wyeth and Progenics Pharmaceuticals Announce Submission of Marketing Application in Europe for the Subcutaneous Formulation of Methylnaltrexone
May 09, 07
08:12 ET	FDA Re-Inspection Results in Positive Re-Classification of Guayama Facility
06:01 ET	Wyeth Presents Phase 3 Data for Pristiq, an Investigational Non-Hormonal Therapy for Menopausal Hot Flashes and Night Sweats
Apr 27, 07
11:47 ET	Wyeth to Present at the Deutsche Bank Annual Health Care Conference
08:45 ET	Wyeth Chief Financial Officer and Vice Chairman Kenneth J. Martin to Leave the Company
Apr 26, 07
14:06 ET	Wyeth Annual Meeting of Stockholders and Declaration of Common and Preferred Stock Dividends
Apr 24, 07
15:21 ET	Wyeth Receives Approvable Letter from FDA for Bazedoxifene for the Prevention of Postmenopausal Osteoporosis
Apr 23, 07
16:03 ET	Wyeth Announces Webcast for Annual Meeting of Stockholders
Apr 19, 07
06:30 ET	Wyeth Reports Earnings Results for the 2007 First Quarter
Apr 06, 07
14:10 ET	Wyeth Provides Update on FDA Review of the Torisel New Drug Application
Apr 05, 07
11:50 ET	West Nile Virus Continues to be a Threat to Unvaccinated Horses
08:30 ET	Wyeth Provides Guayama Update
Apr 03, 07
17:24 ET	New Analysis of Data from WHI Provides Reassurance With Respect to Coronary Heart Disease For Newly Menopausal Women Considering Hormone Therapy
08:00 ET	Wyeth Completes Purchase of Wyeth K.K. Japan
Mar 30, 07
02:30 ET	Safety Analyses of Clinical Data for Bifeprunox in Patients with Schizophrenia Showed a Favorable Weight and Lipid Profile, Similar to Placebo
Mar 26, 07
10:30 ET	Wyeth Receives FDA Approval for New BeneFIX Features That Provide Hemophilia B Patients a Simpler and More Convenient Preparation Process for Recombinant Factor IX
Mar 23, 07
09:29 ET	Wyeth Salutes World Health Organization Call to Action to Combat Pneumococcal Disease
Mar 22, 07
19:28 ET	Wyeth Announces Pricing of $2.5 Billion of Notes
Mar 09, 07
08:50 ET	Wyeth Sets Webcast and Conference Call for 2007 First Quarter Earnings
Mar 06, 07
16:05 ET	Wyeth and Progenics to Begin Clinical Testing of a New Formulation of Oral Methylnaltrexone Based on Phase 2 Findings
Mar 01, 07
08:00 ET	European Committee Issued Positive Opinions to Extend Indication for PREVENAR to Include Pneumonia and Otitis Media
Feb 28, 07
16:05 ET	Wyeth Provides Update on Timing of FDA Inspection of Guayama Facility, Reaffirms 2007 Guidance and Comments on Hormone Therapy Litigation
Feb 22, 07
16:23 ET	Wyeth Pharmaceuticals Announces Organizational Change
14:26 ET	Wyeth Announces Executive Promotion
Feb 20, 07
11:33 ET	Philadelphia Hormone Therapy Trial Completed
Feb 15, 07
16:39 ET	Wyeth Wins Little Rock Hormone Therapy Trial
Feb 09, 07
15:38 ET	Wyeth Applauds Governments' Decision to Fund Pneumococcal Vaccine for Developing Countries
Feb 05, 07
08:00 ET	Wyeth Pharmaceuticals and MediVas Announce Research Partnership to Develop Advanced Hemophilia Therapies
02:00 ET	Wyeth Pharmaceuticals and Nautilus Biotech Announce Collaboration to Develop Hemophilia Therapies
Feb 02, 07
12:45 ET	FDA Approves New Dosing Recommendations for RAPAMUNE in High Immunologic Risk Renal Transplant Patients
08:35 ET	Wyeth to Present at the Merrill Lynch 2007 Global Pharmaceutical, Biotechnology and Medical Device Conference
08:21 ET	Texas Hormone Therapy Lawsuit Has Been Dismissed
Jan 30, 07
07:00 ET	Wyeth Reports Earnings Results for the 2006 Fourth Quarter and Full Year
Jan 29, 07
11:50 ET	Wyeth Pharmaceuticals Listed as the Best 10 Pipeline for the Third Consecutive Year by R&D Directions Magazine
Jan 26, 07
13:36 ET	Wyeth Announces Executive Promotion
Jan 25, 07
16:39 ET	Wyeth Declares Common and Preferred Stock Dividends
Jan 23, 07
15:37 ET	Wyeth Receives Approvable Letter From FDA for Pristiq (Desvenlafaxine Succinate) for the Treatment of Major Depressive Disorder
Jan 11, 07
07:00 ET	Wyeth and Solvay Enter Into an Additional Neuroscience Collaboration
Jan 05, 07
11:09 ET	Wyeth to Present at the JP Morgan Healthcare Conference
Dec 22, 06
08:37 ET	Wyeth to Present at the Morgan Stanley Pharmaceutical CEOs Unplugged Conference
Dec 20, 06
08:00 ET	Wyeth and Progenics Initiate Second Global Phase 3 Trial of Intravenous Methylnaltrexone to Treat Post-operative Ileus
Dec 19, 06
08:31 ET	FDA Grants Torisel NDA Priority Review Status
Dec 06, 06
13:29 ET	Wyeth Sets Webcast and Conference Call for 2006 Fourth Quarter and Full Year Earnings
08:17 ET	Bifeprunox Showed Improvement of Symptoms and Maintenance of Stability with Fewer Metabolic Side Effects vs. Placebo in Patients with Schizophrenia
Nov 30, 06
10:41 ET	Wyeth Does Not Endorse Below-Market Offer by TRC for Up to 0.15 Percent of Wyeth's Stock
10:07 ET	Wyeth Applauds GAVI Alliance's Decision to Fund Pneumococcal Vaccine for Developing Countries
Nov 16, 06
14:23 ET	Wyeth Announces Executive Promotion
14:10 ET	Wyeth Receives 2006 Scrip Award for 'Management Team of the Year'
12:54 ET	Wyeth Declares Increase in Preferred Stock Dividend
12:54 ET	Wyeth Declares Preferred Stock Dividend
Nov 13, 06
11:11 ET	Wyeth Corrects Time of Presentation at the Credit Suisse First Boston Healthcare Conference
Nov 10, 06
09:47 ET	Wyeth to Present at the Credit Suisse First Boston Healthcare Conference
Nov 03, 06
09:00 ET	Wyeth Scientists Receive 2006 Thomas Alva Edison Patent Award for Potential New Therapy for the Prevention of Osteoporosis
Oct 27, 06
10:00 ET	Wyeth's Chief Medical Officer, Gary Stiles, M.D. Named One of 'America's Top Cardiologists' By Consumers' Research Council of America
Oct 25, 06
16:45 ET	Wyeth Presents Data on a Tissue Selective Estrogen Complex Class for Menopausal Therapy
10:17 ET	Wyeth Selected as one of the U.S. Environmental Protection Agency's Best Workplaces for Commuters for Third Consecutive Year
Oct 20, 06
08:00 ET	Wyeth Ranked 11th Among Top 20 Biotech and Pharmaceutical Employers by Science Magazine
Oct 19, 06
07:05 ET	Wyeth Reports Earnings Results for the 2006 Third Quarter and First Nine Months
Oct 12, 06
07:00 ET	Solvay Pharmaceuticals and Wyeth Announce Submission of New Drug Application for Bifeprunox to Treat Schizophrenia
Oct 11, 06
13:43 ET	Wyeth Responds to Mistrial in Philadelphia Hormone Therapy Case
Oct 06, 06
08:00 ET	Wyeth Submits NDA and MAA for Torisel for the Treatment of Advanced Renal Cell Carcinoma
Oct 05, 06
14:00 ET	Wyeth Presents R&D Highlights at Investor Conference
06:30 ET	Wyeth Raises 2006 Full Year Guidance to $3.12 to $3.18 Pro Forma Diluted Earnings Per Share - An Increase of 13% to 16% over 2005
Oct 04, 06
16:56 ET	Philadelphia Hormone Therapy Trial Finishes First Phase
Oct 02, 06
12:10 ET	Wyeth Announces Analyst Meeting Webcast
Sep 29, 06
13:00 ET	New Data Examines TYGACIL (Tigecycline) in Patients with Community-Acquired Pneumonia
Sep 28, 06
14:32 ET	Wyeth Declares Increase In Common Stock Dividend
14:27 ET	Wyeth Board Adopts Corporate Governance Changes
14:21 ET	Wyeth Announces the Election of Raymond J. McGuire to Its Board of Directors
Sep 25, 06
08:00 ET	Wyeth Selected for Ninth Consecutive Year as One of Working Mother Magazine's '100 Best Companies for Working Mothers'
Sep 21, 06
11:52 ET	Wyeth to Present at the UBS Global Life Sciences Conference
Sep 18, 06
09:00 ET	Science Spectrum Magazine Honors Five Wyeth Research Scientists
Sep 15, 06
16:32 ET	Jury Finds in Favor of Wyeth in Hormone Therapy Case
Sep 13, 06
15:04 ET	Wyeth Sets Webcast and Conference Call for 2006 Third Quarter Earnings
Sep 08, 06
14:28 ET	Wyeth to Present at the Bear Stearns 19th Annual Healthcare Conference
Sep 06, 06
13:36 ET	Menopause Awareness Month Highlights Need for Education
Aug 29, 06
15:29 ET	Re-formatted Data Submission Results in Extension of FDA Review for Desvenlafaxine Succinate
Aug 22, 06
14:53 ET	FDA Cancels Advisory Committee Meeting to Review Desvenlafaxine Succinate Data for Major Depressive Disorder
08:00 ET	Wyeth and Progenics Pharmaceuticals Announce Initiation of Phase 2 Clinical Trial of Oral Methylnaltrexone
Jul 20, 06
07:00 ET	Wyeth Reports Earnings Results for the 2006 Second Quarter and First Half
Jul 12, 06
16:05 ET	Wyeth Provides 2006 Mid-Year Business Update
Jul 06, 06
08:52 ET	King Pharmaceuticals and Wyeth Announce Restructuring of Co-Promotion Agreement for ALTACE(R)
Jun 28, 06
16:54 ET	Dr. George Ellestad Receives ACS Medicinal Chemistry Award
15:08 ET	Wyeth Receives Approvable Letter From the FDA for Lybrel
Jun 26, 06
10:20 ET	Wyeth Submits Two New Drug Applications for Women's Health Therapies
Jun 22, 06
10:51 ET	Wyeth Declares Common and Preferred Stock Dividends
Jun 14, 06
08:30 ET	Wyeth Consumer Healthcare Announces the Availability of Advil PM
Jun 04, 06
07:00 ET	Wyeth Announces Preliminary Results of an Ongoing Study of Temsirolimus for the Treatment of Advanced Renal Cell Carcinoma as Presented at ASCO
May 25, 06
14:32 ET	Desvenlafaxine Succinate (DVS-233) Phase 3 Data Show Significant Improvement in Symptoms of Depression in Adult Patients Versus Placebo
May 24, 06
08:30 ET	Seventh Amendment to Nationwide Diet Drug Settlement Receives Final Judicial Approval
May 23, 06
15:00 ET	New Study Reports Venlafaxine Extended Release May Help Adult Patients Prevent New Episodes of Depression for Up to Two Years
May 18, 06
10:30 ET	Wyeth Launches New Customer-centric Web Site
May 16, 06
14:00 ET	Wyeth Sets Webcast and Conference Call for 2006 Second Quarter Earnings
10:00 ET	Wyeth Announces New Head of Corporate Diversity Effort
May 12, 06
10:00 ET	Wyeth to Present at the Bank of America Health Care Conference
May 08, 06
16:01 ET	New Findings From Two Studies on Lybrel Presented at ACOG
16:01 ET	Wyeth Comments on New Report From The Nurses' Health Study Published Today in the Archives of Internal Medicine
Apr 28, 06
10:44 ET	Wyeth to Present at the Deutsche Bank Annual Health Care Conference
Apr 27, 06
14:00 ET	Wyeth Announces Executive Promotions
12:30 ET	Wyeth Annual Meeting of Stockholders and Declaration of Common and Preferred Stock Dividends
Apr 25, 06
16:00 ET	Wyeth Statement on the Citizen Petition Filed With the FDA Related to Bio-Identical Hormone Replacement Therapy
Apr 21, 06
06:59 ET	Wyeth Reports Earnings Results for the 2006 First Quarter
Apr 20, 06
08:57 ET	Wyeth Announces Webcast for Annual Meeting of Stockholders
Apr 11, 06
16:01 ET	New Data From the Women's Health Initiative Study Show No Increased Risk of Breast Cancer with Conjugated Estrogens Alone
Apr 07, 06
03:00 ET	Wyeth Acquires an Additional Stake in Wyeth K.K. Japan
Apr 03, 06
10:00 ET	Wyeth Pharmaceuticals Announces Scottish Collaboration to Enhance Translational Medicine Research
Mar 28, 06
15:51 ET	Wyeth Wins Philadelphia Diet Drug Trial and Summarizes First Quarter Diet Drug Trial Results
11:00 ET	Wyeth Launches Unique Spanish-Language Patient Education and Support Program for EFFEXOR XR Depression Patients
Mar 23, 06
18:33 ET	First Phase of Philadelphia Diet Drug Trial Completed
Mar 21, 06
15:36 ET	Wyeth Wins Philadelphia Diet Drug Trial
Mar 20, 06
12:55 ET	Wyeth Wins Beaumont Texas Diet Drug Trial
Mar 16, 06
17:05 ET	Wyeth Pharmaceuticals Announces Termination of Phase 3 Clinical Program with Oral Temsirolimus in Women with Metastatic Breast Cancer
Mar 13, 06
09:28 ET	Wyeth Sets Webcast and Conference Call For 2006 First Quarter Earnings
Mar 07, 06
13:55 ET	Wyeth to Present at the Lehman Brothers Ninth Annual Global Healthcare Conference
Mar 03, 06
10:10 ET	Wyeth to Present at the SG Cowen & Co. 26th Annual Healthcare Conference
Mar 02, 06
12:00 ET	Wyeth Pharmaceuticals' Antibiotic TYGACIL Receives 'Positive Opinion' From European Regulatory Authority
Mar 01, 06
15:41 ET	Wyeth Wins Texas Diet Drug Trial
Feb 24, 06
16:10 ET	Wyeth Wins Philadelphia Diet Drug Case
Feb 23, 06
11:38 ET	Wyeth to Present at the Citigroup Health Care Conference
Feb 15, 06
12:40 ET	Wyeth Pharmaceuticals Named to R&D Directions Top 10 Pipeline List as 'The Strongest Primary-Care Pipeline'
Feb 13, 06
16:00 ET	New Data from Women's Health Initiative Study Show No Increased Risk of Coronary Heart Disease with Conjugated Estrogens Alone In Any Age Group Studied
Feb 07, 06
16:02 ET	Wyeth Announces Extension of Senior Note Exchange Offer
Feb 06, 06
11:58 ET	Wyeth to Present at the Merrill Lynch 2006 Global Pharmaceutical, Biotechnology and Medical Device Conference
Jan 31, 06
07:03 ET	Wyeth Reports Earnings Results for the 2005 Fourth Quarter and Full Year
Jan 27, 06
16:30 ET	Wyeth Declares Common and Preferred Stock Dividends
Jan 23, 06
16:03 ET	Wyeth Wins Missouri Diet Drug Trial
Jan 13, 06
15:35 ET	Wyeth-Teva Settlement Finalized
Jan 09, 06
16:40 ET	Wyeth Provides Financial Guidance for 2006
16:05 ET	Wyeth to Provide Financial Guidance for 2006 on January 9, 2006
Jan 05, 06
15:05 ET	Wyeth to Present at the JP Morgan Healthcare Conference
Jan 03, 06
12:06 ET	Wyeth Announces Strategic Collaboration with Trubion Pharmaceuticals
Dec 22, 05
15:26 ET	Wyeth Submits New Drug Application for Desvenlafaxine Extended Release (DVS-233) for Depression
09:04 ET	Wyeth to Present at the Morgan Stanley Pharmaceutical CEOs Unplugged Conference
Dec 16, 05
13:30 ET	New Data Highlight TYGACIL (tigecycline) In Vitro Activity Against Resistant Gram-Negative and Extended-Spectrum Beta-Lactamase-Producing Bacteria
Dec 12, 05
14:45 ET	Wyeth Sets Webcast and Conference Call for 2005 Fourth Quarter and Full Year Earnings
Dec 08, 05
09:55 ET	Wyeth Receives Honors at the 2005 Scrip Awards
Dec 02, 05
14:36 ET	FTC Will Not File Objections to Settlement of Patent Dispute Between Wyeth and Teva over Venlafaxine
Dec 01, 05
11:11 ET	Wyeth Enters into $32 Million Contract with National Institutes of Health (NIH) for Ongoing HIV Vaccine Research
Nov 21, 05
14:48 ET	EFFEXOR XR Approved for the Treatment of Panic Disorder
Nov 17, 05
14:46 ET	Wyeth Announces Executive Promotions
13:53 ET	Wyeth Declares Preferred Stock Dividend
13:52 ET	Wyeth Announces the Election of Victor F. Ganzi to its Board of Directors
Nov 08, 05
17:33 ET	Wyeth Announces Pricing of $1.5 Billion of Senior Notes
Nov 03, 05
19:14 ET	Wyeth Wins Los Angeles Diet Drug Trial
10:00 ET	Wyeth to Present at the CIBC World Markets' 16th Annual Healthcare Conference
Nov 02, 05
07:00 ET	Emilio A. Emini, Ph.D., Appointed Executive Vice President, Vaccines Research and Development, Wyeth Pharmaceuticals
Oct 31, 05
15:00 ET	Wyeth Wins Philadelphia Diet Drug Trial
Oct 21, 05
18:10 ET	Wyeth Wins Philadelphia Diet Drug Case
07:16 ET	Wyeth Reports Earnings Results for the 2005 Third Quarter and First Nine Months
Oct 19, 05
09:30 ET	Wyeth Selected as One of the U.S. Environmental Protection Agency's Best Workplaces for Commuters for Second Consecutive Year
Oct 18, 05
17:38 ET	Wyeth and Teva Announce Settlement of Effexor XR(R) Litigation
Oct 17, 05
16:00 ET	First Scientific Data for Lybrel(TM) Presented at ASRM Meeting
Oct 11, 05
09:15 ET	Wyeth to Phase Out Production at Rouses Point, NY Facility
Oct 06, 05
16:06 ET	Wyeth Comments on 2005 Third Quarter and Full Year Earnings Guidance and Provides Earnings Growth Estimate for 2006
Sep 30, 05
09:00 ET	Wyeth Makes Debut Amongst Top 20 Biotech and Pharmaceutical Employers in Science Magazine 2005 Survey
Sep 29, 05
15:26 ET	Wyeth Announces Election of Jeffrey E. Keisling, Vice President, Corporate Information Services and Chief Information Officer
15:05 ET	Wyeth Declares Increase in Common Stock Dividend
14:29 ET	Wyeth Announces the Election of Gary L. Rogers to the Board of Directors
Sep 22, 05
11:48 ET	Wyeth to Present at the UBS Global Life Sciences Conference
Sep 12, 05
08:01 ET	Wyeth Selected for Eighth Consecutive Year as One of Working Mother Magazine's '100 Best Companies for Working Mothers'
Sep 09, 05
09:00 ET	Wyeth to Present at the Bear Stearns 18th Annual Healthcare Conference
Sep 08, 05
12:12 ET	Wyeth Sets Webcast and Conference Call for 2005 Third Quarter Earnings
02:00 ET	Wyeth Opens World's Largest Integrated Biotech Production Facility
Sep 02, 05
16:42 ET	Wyeth Announces Additional Emergency Prescription Assistance Programs to Support Hurricane Katrina Relief Efforts
Sep 01, 05
16:24 ET	Wyeth Announces $1 Million Donation in Support of Hurricane Katrina Relief Efforts
10:47 ET	Wyeth Sells its Marietta, Pennsylvania Manufacturing Facility to GlaxoSmithKline
Aug 16, 05
08:01 ET	Wyeth Launches Unique Education and Support Program for Depression Patients Using Effexor XR(R)
Aug 02, 05
16:01 ET	Wyeth Supports PhRMA Guiding Principles for Direct-To-Consumer Advertising
Jul 27, 05
13:30 ET	Wyeth's New Drug Application for New Oral Contraceptive With Uninterrupted Dosing Regimen Accepted for Filing at FDA
Jul 20, 05
06:53 ET	Wyeth Reports Earnings Results for the 2005 Second Quarter and First Half
Jul 11, 05
09:00 ET	Wyeth Launches Educational Campaign for Women About the Importance of Consulting a Health Care Professional at Menopause
08:30 ET	King Pharmaceuticals, Wyeth and Jack Nicklaus Announce 2nd Annual Jack Nicklaus Heart and Stroke Challenge to Raise Money for Cardiovascular Research and Education
Jun 27, 05
16:02 ET	Wyeth Raises 2005 Full Year Guidance to $2.80 to $2.90 Diluted Earnings Per Share
Jun 23, 05
16:01 ET	Wyeth Announces Executive Promotions
14:56 ET	Wyeth Declares Common Stock Dividend
14:53 ET	Wyeth Declares Preferred Stock Dividend
Jun 16, 05
08:00 ET	FDA APPROVES TYGACIL(TM), FIRST-IN-CLASS ANTIBIOTIC
Jun 10, 05
09:00 ET	Wyeth to Present at the Goldman Sachs Twenty-Sixth Annual Global Healthcare Conference
Jun 08, 05
11:28 ET	Wyeth Sets Webcast and Conference Call for 2005 Second Quarter Earnings
May 27, 05
16:33 ET	Judge Postpones Second Phase of Diet Drug Trial Until July 25, 2005
May 26, 05
09:30 ET	Wyeth to Present at the Friedman Billings Ramsey 9th Annual Growth Investor Conference
May 19, 05
15:46 ET	Philadelphia Diet Drug Trial Finishes First Phase
May 12, 05
13:45 ET	Wyeth Announces Judge Overturns Verdict and Orders New Trial
Apr 29, 05
13:00 ET	Wyeth to Present at the Deutsche Bank Annual Health Care Conference
Apr 27, 05
18:33 ET	Philadelphia Diet Drug Trial Completed
Apr 22, 05
14:32 ET	Wyeth Wins Philadelphia Diet Drug Trial
Apr 21, 05
16:43 ET	Wyeth Annual Meeting of Stockholders and Declaration of Common and Preferred Stock Dividends
Apr 20, 05
16:39 ET	Wyeth Sets Webcast for Annual Meeting of Stockholders
07:02 ET	Wyeth Reports Earnings Results for the 2005 First Quarter
Apr 19, 05
09:03 ET	InductOs(TM) (rhBMP-2/ACS) Receives Additional European Commission Marketing Authorization
Apr 08, 05
16:11 ET	Wyeth Wins Philadelphia Phase II Diet Drug Cases
Apr 07, 05
11:34 ET	Wyeth Joins Nationwide Program to Assure Patient Access to Important Pharmaceutical Products
08:02 ET	Purchase of Additional Wyeth K.K. Equity by Wyeth from Takeda Changes Control
Apr 01, 05
16:39 ET	Jury Splits Verdict in Philadelphia Diet Drug Trial
Mar 30, 05
17:34 ET	Split Verdict in Philadelphia Diet Drug Cases
Mar 24, 05
11:18 ET	Wyeth to Present at the Smith Barney Citigroup Health Care Conference
10:00 ET	New Data Show Most Postmenopausal Women in Study Who Initiated Therapy With Wyeth's Low Dose Hormone Therapies Achieved Increased Bone Mineral Density
Mar 23, 05
14:00 ET	NIH State-of-the-Science Panel Supports Use of Hormone Therapy for Treatment of Moderate to Severe Menopausal Symptoms
Mar 21, 05
16:11 ET	Wyeth Comments on Earnings Guidance for 2005 First Quarter; Addresses Analyst Estimates
09:05 ET	Wyeth Vaccines Researchers Honored by Pharmaceutical Industry
Mar 15, 05
17:16 ET	Wyeth Responds to Patent Lawsuit Ruling
15:22 ET	Federal District Court Approves Seventh Amendment to National Diet Drug Settlement
Mar 11, 05
08:46 ET	Wyeth to Present at the SG Cowen & Co. 25th Annual Healthcare Conference
08:41 ET	Wyeth Sets Webcast and Conference Call For 2005 First Quarter Earnings
Feb 28, 05
15:00 ET	Wyeth and Lawyers Representing Diet Drug Plaintiffs Advance Settlement Discussions
Feb 24, 05
12:28 ET	Wyeth Wins Philadelphia Diet Drug Trial
Feb 23, 05
19:24 ET	Verdict in Philadelphia Diet Drug Case Set Aside by Trial Judge
Feb 09, 05
09:30 ET	Wyeth Named to R&D Directions Top 10 Pipeline List as 'The Pipeline to Watch'
Feb 04, 05
10:30 ET	Wyeth to Present at the Merrill Lynch 2005 Global Pharmaceutical, Biotechnology and Medical Device Conference
08:30 ET	Wyeth Announces Election of James J. Pohlman As Vice President - Corporate Strategic Initiatives
Jan 31, 05
19:14 ET	Veterinary Medicine Advisory Committee Reviews Data on ProHeart 6
07:06 ET	Wyeth Reports Results for the 2004 Fourth Quarter and Full Year
Jan 28, 05
08:30 ET	FDA Grants Tygacil(TM) (Tigecycline) NDA Priority Review Status
Jan 27, 05
15:45 ET	Wyeth Declares Preferred Stock Dividend
15:44 ET	Wyeth Declares Common Stock Dividend
Jan 25, 05
17:15 ET	Wyeth Prevails: U.S. Court of Appeals Affirms Prior U.S. District Court Ruling That Natural Biologics Misappropriated Company Trade Secrets
08:31 ET	Japan's Regulatory Body Approves ENBREL to Treat Rheumatoid Arthritis
Jan 18, 05
08:55 ET	Wyeth Confirms Discussions on Resolution of Downstream Opt-Out Claims
Jan 10, 05
08:18 ET	Wyeth Confirms Support for Proposed Seventh Amendment to National Diet Drug Settlement
Jan 07, 05
09:14 ET	Wyeth Reschedules Announcement of 2004 Fourth Quarter and Full Year Earnings
Jan 06, 05
14:24 ET	Wyeth to Present at the 23rd Annual JP Morgan Healthcare Conference
Jan 04, 05
17:57 ET	Philadelphia Diet Drug Trial Completed
Dec 30, 04
11:34 ET	Wyeth to Present at the Morgan Stanley Pharmaceutical CEOs Unplugged Conference
Dec 22, 04
18:13 ET	Philadelphia Diet Drug Trial Finishes First Phase
15:00 ET	Wyeth Wins One of Two Philadelphia Diet Drug Cases
Dec 15, 04
10:52 ET	Wyeth Seeks Global Regulatory Approval of Tygacil(TM) (Tigecycline) for Injection
Dec 13, 04
14:59 ET	Wyeth Sets Webcast and Conference Call for 2004 Fourth Quarter Earnings
Dec 06, 04
10:33 ET	Wyeth Affirms the Safety and Efficacy of EFEXOR and EFEXOR XL in Response to MHRA Actions on SSRI's and EFEXOR
Nov 23, 04
17:35 ET	Philadelphia Trial Results in Split Verdict
Nov 18, 04
11:50 ET	Wyeth to Present at the Credit Suisse First Boston Healthcare Conference
Nov 17, 04
14:38 ET	Wyeth Declares Preferred Stock Dividend
Nov 16, 04
08:41 ET	Wyeth to Present at the Credit Suisse First Boston Healthcare Conference
Nov 12, 04
08:00 ET	Wyeth Pharmaceuticals Scientists Receive 2004 Thomas Alva Edison Patent Award
Nov 08, 04
11:18 ET	Wyeth to Present at the CIBC World Markets Fifteenth Annual Healthcare Conference
Nov 03, 04
14:30 ET	Philadelphia Diet Drug Trial Completed
11:13 ET	California Diet Drug Trial Completed
03:30 ET	Phase III Study Examines Activity of Tigecycline in Patients With Serious Intra-Abdominal Infections
Oct 27, 04
16:39 ET	Philadelphia Trial Results in Split Verdict; Wyeth Prevails in Two Cases, While Jury Finds $50,000 in Damages in Fernandez Case
Oct 22, 04
15:15 ET	Philadelphia Trial Results in Split Verdict; Wyeth Prevails in One Case, While Jury Awards $41,000 in Compensatory Damages in Second Case
Oct 20, 04
16:22 ET	Wyeth Supports NOF and Surgeon General's Focus on Prevention of Osteoporosis and Promotion of Bone Health; Calls for Consideration of Latest Guidelines
07:07 ET	Wyeth Reports Earnings Results for the 2004 Third Quarter and First Nine Months
Oct 05, 04
08:03 ET	New Guidelines Confirm the Clinical Value of Hormone Therapy for Treatment of Menopausal Symptoms and Protection of Bone Health
Sep 30, 04
15:21 ET	European Commission Approves ENBREL, a Novel Therapy for Treatment of Psoriasis
Sep 09, 04
15:33 ET	Wyeth to Present at the Bear Stearns 17th Annual Healthcare Conference
Sep 03, 04
17:08 ET	Fort Dodge Animal Health to Voluntarily Recall ProHeart(R)6
Sep 01, 04
11:25 ET	Wyeth Announces Election of Thomas Hofstaetter, Ph.D. to Senior Vice President, Corporate Business Development
Aug 26, 04
15:07 ET	Court Grants Preliminary Approval of Seventh Amendment to National Diet Drug Settlement
Aug 23, 04
09:01 ET	Wyeth Oncology Researchers Honored with ACS Heroes of Chemistry Award
Aug 20, 04
16:34 ET	Philadelphia Diet Drug Trial Completed
Aug 17, 04
10:00 ET	FDA Grants Fast Track Status to Temsirolimus, an Investigational Drug for First-Line Treatment of Patients With Advanced Renal Cell Carcinoma
Aug 16, 04
10:00 ET	Wyeth Launches National Advertising Campaign for Hormone Therapy Featuring the Lowest Effective Dose of PREMPRO(TM)
Aug 12, 04
16:11 ET	Wyeth Wins Multiple Philadelphia Diet Drug Cases
Aug 11, 04
09:05 ET	Wyeth and Class Members' Legal Counsel Seek Preliminary Approval of Seventh Amendment to National Diet Drug Settlement
Aug 09, 04
11:21 ET	Dr. Robert Ruffolo, President, Wyeth Research Named Chief Scientific Officer of the Year at 2004 Pharmaceutical Achievement Awards
Aug 06, 04
13:19 ET	Philadelphia Jury Returns Verdict in Diet Drug Case
Aug 04, 04
15:34 ET	Wyeth Announces Executive Promotions
Jul 30, 04
16:57 ET	Wyeth Wins Philadelphia Diet Drug Trial - Jury Finds in Favor of Wyeth in Cannon Case -
11:45 ET	ENBREL Receives Positive Opinion From Regulators for Treatment of Psoriasis in European Union
Jul 27, 04
19:11 ET	Philadelphia Diet Drug Trial Completed - Jury Finds in Favor of Wyeth in One Case and Awards Second Plaintiff $48,000 -
Jul 22, 04
15:34 ET	Wyeth Reaches Agreement with Counsel for Class Members on Terms of New Diet Drug Claims Process
Jul 21, 04
06:56 ET	Wyeth Reports Earnings Results for the 2004 Second Quarter and First Half
Jul 19, 04
14:49 ET	Wyeth Sets Webcast And Conference Call for 2004 Second Quarter and First Half Earnings
Jul 13, 04
17:05 ET	Court Extends Stay of National Diet Drugs Claims Processing
Jul 08, 04
13:15 ET	Centers for Disease Control and Prevention Recommends Resumption of 3rd Dose of Prevnar
Jun 22, 04
16:05 ET	Findings from WHI Memory Study Published in JAMA May Not Directly Apply to Newly Menopausal Women: Study Evaluated Women Who Were on Average 20 Years Past Menopause
Jun 16, 04
15:05 ET	Wyeth Declares Common Stock Dividend
15:05 ET	Wyeth Declares Preferred Stock Dividend
Jun 02, 04
13:00 ET	Wyeth Discusses R&D Strategy and Details Robust Pipeline At Investor Conference
May 26, 04
14:03 ET	Enbrel Receives European Union Approval For Expanded Use In Rheumatoid Arthritis Patients
May 25, 04
17:48 ET	Wyeth to Seek Rehearing of Court Ruling
09:02 ET	Wyeth Announces Analyst Meeting Webcast
May 05, 04
09:00 ET	Wyeth Joins With Class Members' Legal Counsel in Motion For a Stay So That New Diet Drug Claims Process Can Be Negotiated
May 04, 04
10:33 ET	Wyeth Collaborates With the World Health Organization (WHO) on Clinical Trial to Study Possible Alternative Treatment for River Blindness
May 03, 04
14:03 ET	U.S. Food and Drug Administration (FDA) Approves Recombinant Protein Treatment for Tibia Fractures
Apr 29, 04
16:34 ET	Wyeth to Present at Deutsche Bank Securities 2004 Healthcare Conference
Apr 27, 04
17:32 ET	Wyeth to Appeal Verdict in Diet Drug Case
Apr 22, 04
14:38 ET	Wyeth Annual Meeting of Stockholders and Declaration of Common and Preferred Stock Dividends
Apr 21, 04
06:51 ET	Wyeth Reports Earnings Results for the 2004 First Quarter
Apr 19, 04
09:04 ET	Wyeth Sets Webcast and Conference Call for 2004 First Quarter Earnings
Apr 16, 04
13:34 ET	Wyeth Sets Webcast for Annual Meeting of Stockholders
Apr 13, 04
16:00 ET	Latest WHI Data Links PREMARIN(R) to Reduced Incidence of Fracture and Fewer Cases of Breast Cancer
Apr 12, 04
15:03 ET	Wyeth Receives FDA Approval of New Formulation for PROTONIX(R) I.V.
Apr 01, 04
08:34 ET	Wyeth and Solvay Pharmaceuticals to Co-Develop Four Product Candidates and Co-Promote Effexor XR
Mar 25, 04
12:00 ET	Wyeth Announces Discontinuation of Operations in Marietta, PA
Mar 04, 04
14:30 ET	Wyeth Announces Promotion of Eileen M. Lach to Vice President, Corporate Secretary and Associate General Counsel
14:30 ET	Wyeth Declares Preferred Stock Dividend
Mar 02, 04
09:10 ET	Wyeth Responds to Estrogen-Alone Arm of Women's Health Initiative & Reconfirms Important Role of Estrogen Therapy in Symptom Relief and Osteoporosis Prevention
Feb 20, 04
09:15 ET	Lowest Effective Dose of PREMPRO(TM) (0.3 mg/1.5 mg) Now Readily Available In The United States - Trend Toward Lower Dose Hormone Therapy Continues
Feb 12, 04
12:04 ET	Wyeth Reaffirms Distribution Plan for Prevnar(R) to Optimize Product Availability for Children
Jan 30, 04
14:28 ET	Wyeth Pharmaceuticals Receives Subpoena From U.S. Office of Personnel Management
Jan 27, 04
11:40 ET	Wyeth Declares Common Stock Dividend
Jan 26, 04
16:07 ET	Gary L. Stiles, M.D. Appointed Executive Vice President and Chief Medical Officer, Wyeth Pharmaceuticals
Jan 22, 04
07:07 ET	Wyeth Reports Earnings Results for the 2003 Fourth Quarter and Full Year
Jan 20, 04
09:43 ET	ENBREL Receives European Union Approval for the Treatment of Ankylosing Spondylitis
Jan 19, 04
11:23 ET	Wyeth Sets Webcast and Conference Call for 2003 Fourth Quarter and Full Year Earnings
Jan 12, 04
09:02 ET	Wyeth Announces the Election of Robert S. Langer to the Board of Directors
Jan 05, 04
08:42 ET	Wyeth Announces Election of Douglas A. Dworkin As Vice President and Deputy General Counsel
Dec 23, 03
16:00 ET	EFFEXOR(R) XR Remains First and Only SNRI Antidepressant for Long-Term Treatment of Generalized Anxiety Disorder (GAD)
Dec 19, 03
16:26 ET	Wyeth Announces Executive Promotions
Dec 12, 03
08:52 ET	Wyeth Announces Pricing of Floating Rate Convertible Senior Debentures
Dec 11, 03
11:24 ET	Texas Plaintiff In Diet Drug Litigation Case Requests Reduced Award From Court
08:30 ET	Wyeth Tenders for $1.0 Billion of 7.90% Senior Notes Due 2005
Dec 09, 03
16:27 ET	Wyeth Announces Intention to Repurchase Senior Notes And 2003 Fourth Quarter Special Charge
16:24 ET	Wyeth Announces Offering of Senior Notes
16:21 ET	Wyeth Announces Offering of Convertible Senior Debentures
Nov 26, 03
16:05 ET	Shareholder Rights Plan Terminated Early
13:57 ET	Wyeth Prevails in Diet Drug Case
Nov 21, 03
09:06 ET	Wyeth Declares Preferred Stock Dividend
Nov 06, 03
09:29 ET	Wyeth Experiencing Temporary Interruption in Prevnar Shipments
Oct 22, 03
06:53 ET	Wyeth Reports Results for the 2003 Third Quarter and First Nine Months
Oct 20, 03
10:00 ET	Wyeth Sets Webcast And Conference Call For 2003 Third Quarter
Oct 17, 03
11:30 ET	Wyeth Pharmaceuticals Celebrates Grand Opening of Its New Global Headquarters
Oct 09, 03
08:58 ET	Depression Screenings Provide Sufferers With First Step in Helping to Prevent Future Episodes
Sep 30, 03
16:05 ET	Hormone Therapy Reported Effective in Fracture Prevention: Updated WHI Analysis Consistent with Previous Publication
Sep 26, 03
11:15 ET	Comprehensive Pooled Analysis of Antidepressant Studies Demonstrated Significant Efficacy of EFFEXOR (Venlafaxine HCL)/EFFEXOR XR (Venlafaxine HCL)
Sep 25, 03
16:10 ET	Wyeth Declares Common Stock Dividend
15:49 ET	ENBREL Receives Positive Recommendation From European Committee For the Treatment of Ankylosing Spondylitis
15:30 ET	National Influenza Recommendations Updated to Include FluMist, First Intranasal Flu Vaccine in U.S.
Sep 23, 03
08:59 ET	Wyeth Selected For Sixth Year as One of Working Mother Magazine's '100 Best Companies For Working Mothers'
Sep 15, 03
14:06 ET	Court Finds that Natural Biologics Misappropriated Trade Secrets from Wyeth
Sep 09, 03
11:45 ET	FDA Information Campaign Addresses the Appropriate Use of Hormone Therapy
Sep 03, 03
10:48 ET	Wyeth Announces Appointment of Jessica Leigh Stoltenberg as Vice President, Corporate Communications
Aug 06, 03
17:14 ET	Hormone Therapy and Coronary Heart Disease: Updated WHI Analysis Reports No New Findings
Jul 23, 03
07:09 ET	Wyeth Reports Earnings Results for the 2003 Second Quarter and First Half
Jul 21, 03
08:37 ET	Wyeth Sets Webcast and Conference Call for 2003 Second Quarter and First Half Earnings
Jul 17, 03
12:03 ET	Wyeth's New Low Dose Estrogen Tablets Approved for Prevention Of Postmenopausal Osteoporosis
Jul 01, 03
06:00 ET	Now Available - PREMPRO 0.45 mg/1.5 mg - A New Low Dose Hormone Therapy Option
Jun 25, 03
13:52 ET	Wyeth Announces the Election of Lawrence V. Stein as Senior Vice President and General Counsel
13:50 ET	Wyeth Declares Common Stock Dividend
13:49 ET	Wyeth Declares Preferred Stock Dividend
Jun 24, 03
16:00 ET	Report Published in JAMA Updates Breast Cancer Findings First Published in 2002
Jun 10, 03
09:30 ET	The Centers for Disease Control and Prevention's (CDC) Advisory Committee on Immunization Practices (ACIP) Reinstates Recommendation for Administration of Full 4-Dose Series of Prevnar(R)(Pneumococcal 7-valent Conjugate Vaccine Diphtheria CRM197 Protein)
Jun 09, 03
09:04 ET	FDA Approves New Strength of Wyeth Low Dose Hormone Therapy
May 27, 03
16:00 ET	WHIMS Results on Hormone Therapy (HT) Released: Applicability to the Typical HT User Unclear
May 21, 03
07:59 ET	Wyeth and Takeda Sign New Partnership Agreements
May 19, 03
18:01 ET	Landmark Antidepressant Analysis Demonstrated Significant Efficacy of EFFEXOR(R)/EFFEXOR XR
May 15, 03
16:33 ET	Wyeth Reports on Diet Drug Settlement Matrix Claims and Opt Out Forms Received by May 3, 2003
Apr 30, 03
17:00 ET	Significant Reduction in Invasive Pneumococcal Disease Demonstrated in Young Children Since Introduction of Prevnar(R) (Pneumococcal 7-valent Conjugate Vaccine Diphtheria CRM197 Protein)
Apr 29, 03
08:46 ET	FDA Approves Use of ZOSYN(R) in a More Convenient Regimen
Apr 25, 03
15:27 ET	FDA Approves a New Wyeth Low Dose Estrogen Therapy Product; Approval Will Expand Options for Women Seeking Menopausal Symptom Relief
Apr 24, 03
13:03 ET	Wyeth Annual Meeting of Stockholders and Declaration of Common and Preferred Stock Dividends
Apr 23, 03
06:55 ET	Wyeth Reports Earnings Results for the 2003 First Quarter
Apr 21, 03
09:14 ET	Wyeth Sets Webcast and Conference Call for 2003 First Quarter Earnings
Apr 11, 03
16:45 ET	FDA Approves New Indication for RAPAMUNE(R)
Mar 31, 03
14:08 ET	Wyeth Oncology Researchers Honored by Pharmaceutical Industry
Mar 13, 03
09:00 ET	FDA Approves Wyeth's New Low Dose Prempro(TM) Lower Hormone Dose With Efficacy Comparable to the Leading Hormone Therapy
Mar 05, 03
13:54 ET	Wyeth Declares Preferred Stock Dividend
Feb 28, 03
09:37 ET	Wyeth Receives Draft Manuscripts Based on Findings From the Women's Health Initiative Memory Study (WHIMS)
Feb 11, 03
16:34 ET	EFFEXOR(R) XR Approved for the Treatment of Social Anxiety Disorder
Jan 30, 03
14:01 ET	Wyeth Declares Common Stock Dividend
Jan 28, 03
06:51 ET	Wyeth Reports Earnings Results for the 2002 Fourth Quarter and Full Year
Jan 24, 03
11:16 ET	Wyeth Sets Webcast and Conference Call for 2002 Fourth Quarter And Full Year Earnings
Jan 08, 03
11:17 ET	Wyeth Receives FDA Approval of Prescribing Information for Postmenopausal Hormone Therapies
Dec 20, 02
08:51 ET	Wyeth Consumer Healthcare Receives Final Approval for Over-the-Counter Loratadine; Alavert(TM) Shipments Will Begin Today
Dec 19, 02
16:14 ET	U.S. FDA Approves Wyeth Manufacturing Site for Hemophilia A Treatment
Dec 17, 02
10:19 ET	European Commission Grants ENBREL(R) (etanercept) Marketing Authorization for Psoriatic Arthritis
Dec 11, 02
16:30 ET	Wyeth's EFFEXOR(R) XR Significantly Relieves Physical and Emotional Symptoms of Depression and Generalized Anxiety Disorder
Nov 27, 02
14:15 ET	Scientists Reveal Potential New Approach to Treating Muscle Degeneration
Nov 22, 02
13:00 ET	Robert Essner Elected Chairman of Wyeth
Nov 21, 02
16:18 ET	FDA Medical Device Panel Recommends Approval of Wyeth's Product for Open Long-Bone Fractures
12:47 ET	Wyeth Declares Preferred Stock Dividend
Nov 19, 02
10:00 ET	Wyeth Ceases Production of Its Injectable Influenza Vaccine and Pneumococcal Polysaccharide Vaccine
Nov 01, 02
15:09 ET	Wyeth Nutrition Initiates Voluntary Recall of Selected Store Brand Infant Formula From U.S. Marketplace
Oct 24, 02
09:01 ET	Wyeth Pharmaceuticals Calls for Practical Guidance for Women Initiating Hormone Therapy
Oct 22, 02
06:59 ET	Wyeth Reports Earnings Results for the 2002 Third Quarter And First Nine Months
Oct 18, 02
10:05 ET	Wyeth Sets Webcast and Conference Call for Quarterly Earnings
Oct 15, 02
15:34 ET	U.S. Food And Drug Administration Denies Pediatric Exclusivity For Cordarone(R) I.V.
Sep 27, 02
07:04 ET	Wyeth Issues New Earnings Guidance for 2002
Sep 26, 02
16:10 ET	Wyeth Sets Webcast and Analyst Call to Update Earnings Guidance for 2002
13:49 ET	Wyeth Declares Common Stock Dividend
Sep 24, 02
08:45 ET	Wyeth Selected Once Again as One of 'Working Mother' Magazine's '100 Best Companies for Working Mothers'
Sep 18, 02
08:04 ET	Dual-Action EFFEXOR(R) XR, Fastest Growing In Antidepressant Market; EFFEXOR XR Stands Out in Helping Patients Become Virtually Symptom Free
Sep 17, 02
08:00 ET	European Commission Grants Marketing Authorization for Recombinant Protein Treatment for Tibia Fractures
Sep 04, 02
08:01 ET	Wyeth Updates Product Labels For Its Postmenopausal Hormone Therapies Provides New Safety Information For Physicians
Aug 13, 02
16:53 ET	Wyeth Announces The Passing of Bernard Canavan, M.D.
Jul 26, 02
09:01 ET	Back-Up Contraception No Longer Required for Women Using Norplant(R) System
Jul 23, 02
07:05 ET	Wyeth Reports Continued Strong Growth in Net Revenue and Earnings for the 2002 Second Quarter and First Half
Jul 22, 02
14:03 ET	Wyeth Sets Webcast and Conference Call for Quarterly Earnings
Jul 09, 02
07:32 ET	Wyeth Informs Physicians of WHI Findings
Jul 02, 02
16:00 ET	Study in Older Women With Serious Heart Disease (HERS II) Finds HRT Has Neutral Effect on Preexisting Heart Disease
Jun 20, 02
14:15 ET	Wyeth Announces Executive Promotions and Organizational Changes
14:00 ET	Wyeth Announces Election of Robert R. Ruffolo, Jr., Ph.D. as Senior Vice President, Wyeth and President, Wyeth Research
12:46 ET	Wyeth Declares Common Stock Dividend
12:35 ET	Wyeth Declares Preferred Stock Dividend
Jun 10, 02
14:00 ET	Wyeth Discontinues Clinical Program for Its Type-2 Diabetes Candidate
07:00 ET	Wyeth Announces the Sale of its ESI Lederle Generic Injectable Pharmaceuticals Business to Baxter Healthcare Corporation
May 21, 02
16:34 ET	FDA Advisory Panel Supports New Efficacy Data for Pneumococcal 7-valent Conjugate Vaccine (Diphtheria CRM197 Protein), Prevnar(R)
15:55 ET	Wyeth's EFFEXOR(R) (Venlafaxine HCl) Achieved Long-Term (52 Weeks) Remission In 67 Percent of Patients With Recurring Depression
May 08, 02
08:00 ET	After 60 Years, Menopause Has a New Face - 12 Remarkable Women Redefine Life After 50 to Inspire Other Women -
May 06, 02
10:36 ET	Global Factor VIII Supply to Improve Following European Commission Approval, Release of Additional Supply
May 03, 02
11:19 ET	PROTONIX (pantoprazole sodium) Delayed-Release Tablets Approved For Long-Term Treatment of Zollinger-Ellison Syndrome
Apr 25, 02
14:16 ET	Wyeth Announces Election of David A. Manspeizer as Vice President, Intellectual Property and Associate General Counsel
12:19 ET	Wyeth Annual Meeting of Stockholders and Declaration of Common and Preferred Stock Dividends
Apr 24, 02
07:03 ET	Wyeth Reports Continued Strong Growth in Net Revenue And Earnings for the 2002 First Quarter
Apr 22, 02
09:55 ET	Wyeth Sets Webcast and Conference Call for Quarterly Earnings
Mar 21, 02
09:18 ET	Wyeth Announces Survival to Hospital Admission Nearly Doubled When Cordarone(R) I.V. Utilized Instead of Lidocaine in Cardiac Arrest Due to Ventricular Fibrillation and Pulseless Ventricular Tachycardia
Mar 18, 02
09:19 ET	Wyeth Appoints PricewaterhouseCoopers as Auditor
Mar 11, 02
08:01 ET	American Home Products Changes Name to Wyeth, Reflecting Evolution To Global, Research-Based Pharmaceutical Company
Mar 06, 02
10:00 ET	FDA Designates Wyeth-Ayerst's Investigational Treatment for Renal Cell Carcinoma for Fast-Track Development
Mar 05, 02
12:49 ET	American Home Products Corporation Declares Preferred Stock Dividend
12:42 ET	American Home Products Corporation Announces Election Of Mary Katherine Wold as Vice President, Taxes
Feb 19, 02
17:05 ET	American Home Products Announces Promotion of Ulf Wiinberg to President, Whitehall-Robins Healthcare
Feb 05, 02
10:00 ET	Wyeth-Ayerst Leads Collaboration to Enhance Research on Lou Gehrig's Disease
Jan 31, 02
13:39 ET	American Home Products Corporation Declares Common Stock Dividend
Jan 24, 02
17:55 ET	FDA Advisory Committee Rejects New RAPAMUNE(R) Regimen - Wyeth-Ayerst Committed to Working With FDA to Discuss Additional Analyses -
06:59 ET	American Home Products Corporation Reports Continued Growth in Net Revenue and Operating Results for The 2001 Fourth Quarter and Full Year
Jan 22, 02
08:07 ET	Global Factor VIII Supply Shortage Could Ease Following European Committee Positive Opinion
Jan 21, 02
11:07 ET	American Home Products Corporation Sets Webcast And Analyst Call for Quarterly and Year End Earnings
Jan 10, 02
11:17 ET	AHP Diet Drug Settlement Obtains Final Judicial Approval
Dec 20, 01
10:54 ET	American Home Products Reaffirms Earnings Guidance for 2001 and 2002; Pursues New Strategic Initiatives
Dec 17, 01
10:17 ET	American Home Products Comments on Amgen's Acquisition of Immunex Corporation
Dec 04, 01
10:00 ET	Wyeth-Ayerst's Antibody-Targeted Chemotherapy Included in NCCN Oncology Practice Guidelines
Nov 27, 01
09:02 ET	Wyeth-Ayerst Licenses Ludwig Institute Antibody As Potential Novel Anti-Cancer Therapy
Nov 15, 01
11:58 ET	American Home Products Corporation Declares Preferred Stock Dividend
Nov 14, 01
17:01 ET	American Home Products Announces Positive Final Results in First Head-To-Head Randomized Study of Cordarone(R) I.V. (Amiodarone Hcl) Versus Lidocaine
Nov 08, 01
09:03 ET	American Home Products Honored for Its Dedication to Pharmaceutical Research and Development
Nov 07, 01
11:27 ET	American Home Products Corporation Announces Appointment of Charles Portwood As President, Global Supply Chain For Wyeth-Ayerst Pharmaceuticals
Nov 06, 01
11:05 ET	Wyeth Lederle Vaccines and the RIVM Enter Into Exclusive Collaboration to Develop Pneumo/Mening Combination Vaccines
Oct 26, 01
11:31 ET	American Home Products Submits Plan to Produce Smallpox Vaccine
Oct 24, 01
09:38 ET	American Home Products Corporation Reaffirms 2001 Earnings Growth Target And Sets 2002 Earnings Goal
Oct 23, 01
06:58 ET	American Home Products Corporation
Oct 22, 01
11:43 ET	PROTONIX(R) I.V. (Pantoprazole Sodium) Receives Expedited Approval from FDA to Treat Zollinger-Ellison Syndrome
Oct 19, 01
08:54 ET	American Home Products Corporation Sets Webcast and Analyst Call For Quarterly Earnings
Oct 09, 01
08:00 ET	American Home Products Corporation Selected Once Again As One of 'Working Mother' Magazine's '100 Best Companies for Working Mothers'
Sep 20, 01
13:53 ET	American Home Products Corporation Declares Common Stock Dividend
Sep 18, 01
15:22 ET	American Home Products Corporation Announces Contribution to Relief Efforts
Aug 16, 01
16:57 ET	Appeals Court Affirms Diet Drug Settlement
Aug 15, 01
11:03 ET	JAMA Study Showed Hormone Replacement Therapy Significantly Increased Bone Mineral Density in Older Women
Aug 02, 01
11:28 ET	American Home Products Corporation Introduces Tablet Form of Rapamune(R) (sirolimus) - A Novel Immunosuppressant for Kidney Transplant Patients
Jul 24, 01
07:05 ET	American Home Products Corporation Reports Strong Net Revenue and Earnings For the 2001 Second Quarter and First Half
Jul 23, 01
08:32 ET	American Home Products Corporation Sets Webcast and Analyst Call For Quarterly Earnings
02:00 ET	Alzheimer's Disease Immunotherapeutic to Advance to Exploratory Phase 2A Studies
Jul 03, 01
10:21 ET	Wyeth-Ayerst and Taxolog, Inc., Agree to Collaborate To Develop Anti-Tumor Agents
Jun 22, 01
09:14 ET	Wyeth-Ayerst Receives Not-Approvable Letter from FDA for PMA for Recombinant Protein Treatment for Long-Bone Fractures
Jun 21, 01
15:12 ET	American Home Products Corporation Announces Election of Corporate Officers
12:24 ET	American Home Products Corporation Declares Common Stock Dividend
12:20 ET	American Home Products Corporation Declares Preferred Stock Dividend
Jun 14, 01
12:40 ET	FDA Expands Indication for PROTONIX(R) (Pantoprazole Sodium) Delayed-Release Tablets
Jun 13, 01
11:10 ET	Study in JAMA Reaffirms That Early HRT Use Helps Prevent Fractures Due to Osteoporosis
Jun 11, 01
08:45 ET	American Home Products Corporation Announces Extension Of Senior Note Exchange Offer
May 17, 01
08:03 ET	Protonix(R) I.V. (pantoprazole sodium) for Injection - The First and Only Intravenous Proton Pump Inhibitor (PPI) in the U.S. - Now Available for Hospitalized Patients With Acid Reflux
May 16, 01
14:19 ET	American Home Products' New CEO Shares Vision and Growth Strategy
May 14, 01
07:00 ET	American Home Products Corporation Announces Analyst Meeting Webcast
May 10, 01
11:59 ET	Wyeth-Ayerst Laboratories to Experience Stock Outages Of The Snakebite Treatment - Antivenin
May 09, 01
12:52 ET	American Home Products Antidepressant Gains New FDA Labeling Approval for Extended Use
May 08, 01
10:15 ET	American Home Products Announces Significantly Positive Results in First Head-To-Head Randomized Study of Cordarone(R) I.V. (Amiodarone HCl) Versus Lidocaine
May 01, 01
15:31 ET	Wyeth Lederle Vaccines Launches E-commerce Web site; Offers Vaccine Information to Health Care Providers, Parents, and Patients
Apr 26, 01
12:58 ET	American Home Products Corporation Annual Meeting of Stockholders and Declaration of Common and Preferred Stock Dividends
Apr 25, 01
07:06 ET	American Home Products Corporation Reports Strong Net Revenue and Earnings for the 2001 First Quarter
Apr 23, 01
14:35 ET	American Home Products Corporation Sets Webcast And Analyst Call For Quarterly Earnings
Apr 06, 01
12:43 ET	AHP to Pursue Remedies to Overturn Texas Jury Award; Company Remains Confident in Adequacy of Litigation Reserves
Mar 23, 01
10:06 ET	FDA Approves New I.V. Treatment for Hospitalized Patients With Acid Reflux
Mar 20, 01
14:02 ET	Wyeth-Ayerst Introduces www.inResidence.com for Residency Programs
Mar 15, 01
11:28 ET	European Commission Approves Rapamune(R) (sirolimus) An Immunosuppressant for Kidney Transplant Patients
Mar 09, 01
11:56 ET	American Home Products Corporation Announces Appointment of Douglas A. Rogers As President, Whitehall-Robins Consumer Healthcare U.S.
Mar 06, 01
12:55 ET	American Home Products Corporation Declares Preferred Stock Dividend
09:45 ET	Robert A. Essner Named Next CEO of American Home Products Corporation
Feb 26, 01
13:30 ET	American Home Products Corporation Announces The Creation of the Wyeth Women's Health Business Unit
Feb 21, 01
09:02 ET	U.S. FDA Accepts American Home Products Corporation's PMA For Recombinant Protein Treatment for Long-Bone Fractures
Feb 05, 01
02:00 ET	The First and Only Vaccine to Help Prevent Invasive Pneumococcal Disease in Infants and Young Children
Jan 25, 01
07:03 ET	AMERICAN HOME PRODUCTS CORPORATION REPORTS STRONG OPERATING RESULTS:
Jan 23, 01
14:52 ET	American Home Products Corporation Announces Election of Corporate Officers
12:50 ET	American Home Products Corporation Declares Common Stock Dividend
09:56 ET	American Home Products Corporation Sets Webcast and Analyst Call for Quarterly Earnings
Jan 03, 01
16:25 ET	American Heart Association (AHA) Issues New Stroke Guidelines Including Wyeth-Ayerst's/King's ALTACE for People With Diabetes
Dec 11, 00
09:02 ET	Rapamune Receives Unanimous Positive Opinion From The European Medicines Evaluation Agency (EMEA)
Nov 27, 00
15:41 ET	American Home Products Announces the Appointment of Robert R. Ruffolo, Jr., Ph.D. Executive Vice President, Pharmaceutical R&D, Wyeth-Ayerst Research
Nov 16, 00
14:07 ET	American Home Products Corporation Declares Preferred Stock Dividend
Nov 15, 00
09:03 ET	European Commission Grants 'Orphan' Status for New Acute Myeloid Leukemia Treatment
Nov 06, 00
09:54 ET	European Committee Issues Positive Opinion on First Vaccine for Prevention of Invasive Pneumococcal Disease in Infants and Children Up to Two Years Old
Oct 31, 00
18:31 ET	Aviron Submits Biologics License Application for FluMist(TM)
16:22 ET	Aviron Submits Biologics License Application for FluMist(TM)
Oct 30, 00
09:04 ET	American Home Products Corporation Announces The Passing of Robert I. Levy, M.D.
Oct 20, 00
06:00 ET	American Home Products and Aventis Pharma Reach New Agreement for Development and Marketing of Trimegestone
Oct 19, 00
08:57 ET	American Home Products Corporation Reports Continued Strong Sales and Earnings From Continuing Operations for the 2000 Third Quarter and First Nine Months
Oct 09, 00
10:00 ET	Wyeth-Ayerst Continues Transformation to Global e-Business; Introduces a New Web Site as the Centerpiece of its Internet Presence
Oct 05, 00
17:42 ET	ALTACE(R) (Ramipril) Receives New Indication to Reduce Risk of Stroke, Heart Attack and Death From Cardiovascular Causes
Oct 03, 00
16:46 ET	Wyeth-Ayerst Laboratories Enters Into Consent Decree With U.S. Food and Drug Administration
Sep 21, 00
16:31 ET	American Home Products Announces The Election of Justin Victoria to Vice President, Investor Relations
13:46 ET	American Home Products Corporation Declares Common Stock Dividend
13:02 ET	American Home Products Corporation Announces the Appointment Of Walter V. Shipley to the Board of Directors
Sep 13, 00
08:02 ET	Wyeth-Ayerst Laboratories Provides Norplant(R) System Update to Physicians and Patients
Sep 05, 00
11:19 ET	American Home Products Corporation Selected Once Again as One of Working Mother Magazine's '100 Best Companies for Working Mothers'
Aug 29, 00
13:04 ET	American Home Products Corporation Receives Approval for Tablet Form of Rapamune(R) (Sirolimus) - A Novel Immunosuppressant for Kidney Transplant Patients
Aug 28, 00
16:30 ET	Approval Granted for American Home Products' Diet Drug Settlement
Aug 17, 00
19:58 ET	Wyeth-Ayerst Comments on Norplant(R) System
Aug 15, 00
14:19 ET	American Home Products' Cordarone(R) I.V. (amiodarone HCl) Added to American Heart Association Advanced Cardiac Life Support Guidelines
Aug 09, 00
16:15 ET	AHP and Immunex Take Actions to Support Continued Growth of Immunex
Jul 28, 00
16:15 ET	Wyeth-Ayerst Committed to Pursuing European Approval for Kidney Transplant Drug
Jul 20, 00
14:15 ET	American Home Products Corporation Declares Preferred Stock Dividend
13:15 ET	American Home Products Corporation Declares Common Stock Dividend
13:01 ET	American Home Products Corporation Declares Common Stock Dividend
12:10 ET	American Home Products Corporation Announces the Appointment of Richard L. Carrion to the Board Of Directors
12:06 ET	American Home Products Corporation Announces Executive Promotions and Organizational Changes
09:29 ET	American Home Products Corporation Reports Strong Sales and Earnings from Continuing Operations for the 2000 Second Quarter and First Half
Jul 17, 00
14:13 ET	Wyeth-Ayerst's EFFEXOR-XR(R) Receives New Label Change for Long-Term Treatment of Generalized Anxiety Disorder
10:43 ET	American Home Products' Agreements With Celera and Incyte to Boost Genomics Capability
10:04 ET	BASF and LSU Announce Licensing Agreement for CLEARFIELD* Rice
Jul 07, 00
09:01 ET	American Home Products Announces Organizational Changes in its Wyeth-Ayerst Pharmaceutical Division
Jun 30, 00
13:28 ET	American Home Products Corporation Announces the Completion of the Sale of Its Cyanamid Agricultural Products Business to BASF
Jun 28, 00
09:19 ET	Agricore and Cyanamid Announce Global Technology Agreement for CLEARFIELD* Canola
Jun 23, 00
10:09 ET	American Home Products and King Pharmaceuticals Finalize Co-Promotion Arrangement for Altace(R)
Jun 21, 00
18:17 ET	CDC Advisory Committee Votes to Include Wyeth Lederle Vaccines' Prevnar(TM) In The Vaccines for Children Program
Jun 12, 00
15:00 ET	One Year Update on Patients Who Used Diet Drugs Presented at the American Society of Echocardiography Meeting
Jun 07, 00
09:13 ET	Wyeth Lederle Vaccine's Prevnar(TM), First Vaccine for the Prevention of Invasive Pneumococcal Disease in Infants and Children, Recommended by American Academy of Pediatrics
May 18, 00
14:04 ET	American Home Products Gains FDA Approval for Mylotarg(TM); First Antibody-Targeted Chemotherapy Provides High Tech Cancer-Fighting Option
May 17, 00
17:00 ET	Now Available - Protonix(R) (Pantoprazole Sodium) for the Short-Term Treatment Of Erosive GERD and Associated Symptoms, Including Nighttime Heartburn
May 12, 00
16:09 ET	John R. Stafford Undergoes Successful Bypass Surgery
May 02, 00
14:40 ET	American Home Products to Purchase Collegeville Site For New Global Pharmaceutical Headquarters
10:05 ET	Fairness Hearing Begins Today for American Home Products Diet Drug Settlement
Apr 27, 00
12:32 ET	American Home Products Corporation Declares Common Stock Dividend
12:31 ET	American Home Products Corporation Annual Meeting of Stockholders and Declaration of Common and Preferred Stock Dividends
12:28 ET	American Home Products Corporation Declares Preferred Stock Dividend
Apr 19, 00
08:50 ET	American Home Products Corporation Reports Strong Sales and Earnings From Continuing Operations For The 2000 First Quarter
Apr 18, 00
08:46 ET	Cyanamid Expands CLEARFIELD* Corn in Latin America with Registration of LIGHTNING(R) in Mexico
Apr 13, 00
16:33 ET	American Home Products Will Proceed With Nationwide Settlement On Diet Drugs
Apr 05, 00
08:31 ET	American Home Products and Elan Forge Biotech Alliance to Develop Alzheimer's Vaccine
Apr 04, 00
18:11 ET	American Home Products Corporation to Invest $685 Million for New Biotechnology Manufacturing Facility in Ireland
Mar 22, 00
17:32 ET	AHP Announces European Union Approval of MINESSE(R) - Lowest Dose Oral Contraceptive
Mar 21, 00
01:41 ET	American Home Products Corporation Announces the Sale Of Its Cyanamid Agricultural Products Business to BASF
Mar 17, 00
15:18 ET	FDA Advisory Committee Recommends Approval of First Antibody-Targeted Chemotherapy
Mar 13, 00
18:25 ET	Wyeth-Ayerst Media Release: Data in Three New Studies Emphasize Importance of Primary Prevention of Cardiovascular Disease in Postmenopausal Women
Mar 07, 00
12:19 ET	American Home Products Gains FDA Approval for ReFacto(R) -- a Recombinant Therapy for Hemophilia A
Mar 02, 00
14:46 ET	American Home Products Corporation to Donate 10 Million Doses of Haemophilus Influenzae Type B Vaccine
Feb 29, 00
10:08 ET	American Home Products Corporation Announces the Appointment of Jack O'Connor to Vice President and Treasurer
Feb 24, 00
14:49 ET	American Home Products Corporation Declares Preferred Stock Dividend
Feb 17, 00
12:57 ET	American Home Products Receives FDA Approval of Prevnar(TM) the First Vaccine For the Prevention of Invasive Pneumococcal Disease in Infants and Toddlers
Feb 07, 00
15:48 ET	AHP Announces European Union Approval of ENBREL(R) (Etanercept) for Rheumatoid Arthritis
08:52 ET	American Home Products to Receive $1.8 Billion Termination Fee
Feb 02, 00
18:50 ET	FDA Approves Tablet Formulation of Protonix(R) (Pantoprazole Sodium) A New Proton Pump Inhibitor for the Treatment of Erosive Esophagitis
Jan 27, 00
14:34 ET	American Home Products Corporation Declares Common Stock Dividend
10:26 ET	Joint Press Statement
Jan 25, 00
09:43 ET	American Home Products Corporation Reports Sales and Earnings for the 1999 Fourth Quarter and Full Year
Jan 13, 00
10:09 ET	American Home Products' Submission for Tablet Formulation of Rapamune(R) (Sirolimus) Accepted by FDA
Jan 12, 00
18:00 ET	American Home Products Corporation Announces New Chief Financial Officer for Wyeth-Ayerst
16:50 ET	American Home Products Corporation Announces Executive Retirement, Promotions and Organizational Changes
Jan 05, 00
11:47 ET	FDA Accepts and Designates Priority Status to American Home Products Corporation's Novel Treatment for Relapsed Adult Acute Myeloid Leukemia
Dec 21, 99
23:37 ET	American Home Products Corporation Confirms Resolution Of Substantially All Mississippi Diet Drug Cases
19:04 ET	American Home Products to Appeal Mississippi Verdict; National Settlement Continues to Move Forward
11:40 ET	U.S. Registration Granted for EXTREME(TM) and BACKDRAFT(TM) Herbicides
Dec 16, 99
19:58 ET	American Home Products Statement On Pfizer Consent Solicitation Filing
Dec 14, 99
08:16 ET	American Cyanamid and Hyseq Sign Broad Scale Gene Product Agreement
Dec 10, 99
09:47 ET	AHP Remains Committed to Completion of Announced Warner-Lambert Company Merger-of-Equals Agreement
Dec 07, 99
09:25 ET	American Home Products Announces U.K. Patent Infringement Judgment Against Novartis' Rapamycin Derivative
09:04 ET	Antibody-Targeted Chemotherapy With CMA-676 Uses Breakthrough Technology to Treat Leukemia
Dec 03, 99
18:54 ET	American Home Products Gratified by Action of Delaware Chancery Court
Nov 30, 99
13:00 ET	American Home Products Responds Positively to Warner-Lambert Counterclaim
10:07 ET	American Cyanamid and Northwest Plant Breeding Company Sign Research and Commercialization Agreement to Produce Herbicide Tolerant Wheat
Nov 23, 99
17:55 ET	Diet Drug Settlement Receives Preliminary Approval
Nov 19, 99
16:36 ET	American Home Products States That Delaware Court Of Chancery Sets Hearing For January 24, 2000
Nov 18, 99
14:10 ET	American Home Products Corporation Declares Preferred Stock Dividend
Nov 17, 99
14:19 ET	American Cyanamid and Michigan State University Sign Licensing Agreement for Herbicide Tolerant Sugar Beets
Nov 16, 99
08:02 ET	New Cereals Herbicide Controls Galium and Other Difficult Broadleaf Weeds
Nov 08, 99
19:38 ET	American Home Products and Warner-Lambert Outline Powerful Growth Story for AmericanWarner
Nov 05, 99
16:07 ET	American Home Products Intends to Complete Merger With Warner-Lambert
15:18 ET	FDA Advisory Committee Recommends First Pneumococcal Conjugate Vaccine for Children
Oct 22, 99
16:39 ET	CDC Advisory Committee Votes to Recommend First Pneumococcal Conjugate Vaccine for Routine Use in Children
Oct 21, 99
17:35 ET	American Home Products Receives Approval for New Meningitis Vaccine in The United Kingdom
Oct 18, 99
17:38 ET	American Home Products Corporation Briefs Analysts on Research and Development Progress
09:31 ET	American Home Products Corporation Reports Sales and Earnings for the 1999 Third Quarter and First Nine Months
Oct 15, 99
10:23 ET	Wyeth Lederle Vaccines Voluntarily Withdraws from the Market its Rotavirus Vaccine RotaShield(R)
09:07 ET	Wyeth Lederle Vaccines Voluntarily Withdraws from the Market its Rotavirus Vaccine RotaShield(R)
Oct 07, 99
19:51 ET	American Home Products Corporation Adopts Stockholder Rights Plan
12:51 ET	American Home Products Announces Diet Drug Settlement Plan
Oct 06, 99
08:06 ET	American Home Products Corporation Announces a Restructuring of the Cyanamid Agricultural Products Business
Sep 23, 99
14:53 ET	American Home Products Announces Record Dividend
Sep 15, 99
20:00 ET	American Home Products Corporation Receives Approval for Rapamune(R) (Sirolimus) - a Novel Immunosuppressant for Kidney Transplant Patients
19:36 ET	American Home Products Corporation's Cordarone(R) I.V. (amiodarone HCL) Improved Survival to Hospital by 29 Percent
15:11 ET	American Home Products Announces Sonata(R) (Zaleplon) Clears Final Regulatory Hurdle For U.S. Marketing
Sep 03, 99
05:20 ET	American Cyanamid Inventor Honored for Herbicide Discovery
Sep 01, 99
08:35 ET	American Home Products Corporation Selected as One of Working Mother Magazine's '100 Best Companies for Working Mothers'
Aug 31, 99
08:03 ET	Wyeth-Ayerst Laboratories Announces Limited Recall of Tubex(R) Epinephrine Used in Allergic Reaction Kits
Aug 20, 99
10:46 ET	American Home Products Media Statement On Diet Drug Decision In California State Court Denying Class Certification
Aug 16, 99
10:41 ET	American Home Products Announces FDA Approval for Sonata(R) (Zaleplon), A Breakthrough Approach to Treat Insomnia
Aug 06, 99
14:19 ET	American Home Products to Appeal Court's Ruling In Deborah Lovett vs. American Home Products
Jul 29, 99
10:20 ET	Cyanamid and Monsanto Announce Glyphosate Supply Agreement
Jul 27, 99
16:55 ET	FDA Advisory Committee Concludes That American Home Products' Rapamune(R)(Sirolimus) is Safe and Effective for the Prevention of Kidney Transplant Rejection
Jul 22, 99
12:53 ET	American Home Products Corporation Declares Common Stock Dividend
12:47 ET	American Home Products Corporation Declares Preferred Stock Dividend
Jul 21, 99
10:07 ET	American Home Products Corporation's Pneumococcal Conjugate Vaccine for Children Receives Priority Review Status from FDA
09:55 ET	American Home Products Announces Receipt of FDA Approvable Letter for Protonix(R) Intravenous Formulation
Jul 20, 99
09:47 ET	American Home Products Corporation Reports Sales and Earnings for the 1999 Second Quarter and First Half
Jul 15, 99
16:20 ET	American Home Products Corporation's Wyeth Lederle Division Announces Action On Rotavirus Vaccine
Jul 14, 99
13:35 ET	Cyanamid and Nidera Seeds to Develop Herbicide Tolerant Corn
Jul 08, 99
10:53 ET	Cyanamid Launches Global Brand
Jun 30, 99
17:23 ET	American Home Products Announces Receipt of FDA Approvable Letter for Protonix Tablets
Jun 17, 99
16:08 ET	American Home Products Corporation Launches ReFacto in the United Kingdom
Jun 02, 99
09:25 ET	American Home Products Corporation's Wyeth Lederle Vaccines Seeks FDA License For Vaccine to Help Prevent Pneumococcal Disease in Children
Jun 01, 99
16:13 ET	American Home Products Corporation Announces Lower Expected Earnings for the Second Quarter and Year Due to Agricultural and Animal Health Shortfalls
10:24 ET	American Home Products Launches Sonata(R) In Germany
May 27, 99
10:20 ET	American Home Products' RotaShield(R), First Vaccine for Use in Preventing Rotavirus, Receives Marketing Authorization in Europe
May 20, 99
14:43 ET	American Home Products Corporation Declares Preferred Stock Dividend
May 17, 99
09:25 ET	American Home Products Corporation Launches Sonata(R) in Denmark and Sweden
May 06, 99
10:01 ET	First License Submission for Wyeth Lederle Vaccines' Meningococcal C Conjugate Vaccine
Apr 22, 99
13:16 ET	American Home Products Corporation Annual Meeting of Stockholders and Declaration of Common Stock Dividend
Apr 20, 99
08:06 ET	American Home Products Corporation Reports Sales and Earnings for the 1999 First Quarter
Apr 15, 99
18:06 ET	American Home Products Announces European Approval of ReFacto
Mar 17, 99
10:53 ET	American Home Products' Sonata(R) (Zaleplon), First in a New Generation of Drugs to Treat Insomnia, Receives Marketing Authorization in Europe
Mar 15, 99
14:54 ET	Wyeth-Ayerst Announces Bruce Burlington, M.D. Joins Company As Senior Vice President Global Regulatory Affairs
Mar 11, 99
17:45 ET	American Home Products Announces Effexor(R) XR Receives FDA Approval for the Treatment of Generalized Anxiety Disorder
12:52 ET	American Home Products Corporation Announces - FDA Designates Wyeth Lederle Vaccines' Pneumococcal Conjugate Vaccine for Fast-Track Development
Mar 09, 99
16:34 ET	New Study Examining Cardiovascular Status and Duration Of 'Phen-Fen' Treatment Presented at ACC
Mar 02, 99
11:44 ET	American Home Products Corporation Declares Preferred Stock Dividend
Feb 23, 99
14:57 ET	Apollo BioPharmaceutics and American Home Products Enter into Agreement for Development of Estrogen Products for Alzheimer's Disease
Feb 17, 99
12:04 ET	American Home Products Corporation Announces European Filing for Rapamune(R) (Sirolimus) for the Prevention of Kidney Transplant Rejection
Feb 05, 99
14:47 ET	American Cyanamid and Horizon Ag, LLC Announce U.S. Marketing Agreement for Herbicide Tolerant Rice
Feb 01, 99
19:06 ET	American Home Products Corporation Announces That Rapamune(R) (sirolimus) NDA Accepted for Priority Review for the Prevention of Kidney Transplant Rejection
Jan 28, 99
12:23 ET	American Home Products Corporation Declares Common Stock Dividend
Jan 26, 99
09:21 ET	American Home Products Corporation Reports Sales and Earnings for the 1998 Fourth Quarter and Full Year
Jan 20, 99
10:57 ET	Kevin L. Reilly Named President, Wyeth Vaccines and Nutrition, Division of Wyeth-Ayerst Laboratories
Jan 19, 99
15:59 ET	Estradiol Tablets, USP Now Available from ESI Lederle
Jan 12, 99
16:49 ET	Wyeth Lederle Vaccines and Aviron Enter Into Global Collaboration On FluMist(TM); Agreement for Co-Promotion and International Marketing Rights
Dec 10, 98
07:30 ET	Cardiovascular Results Of New Fenfluramine Study Presented At The European Echocardiography Meeting
Nov 19, 98
14:01 ET	American Home Products Corporation Declares Preferred Stock Dividend
Nov 11, 98
11:18 ET	Cardiovascular Results of New Redux/Phen-Fen Study Presented at AHA
11:16 ET	/C O R R E C T I O N -- Wyeth-Ayerst Laboratories/
Nov 05, 98
12:22 ET	New Guide to Prevention and Treatment of Osteoporosis Released
Oct 26, 98
14:00 ET	American Cyanamid and Zeneca Seeds Announce Global Technology Agreement for Herbicide Tolerant Canola
14:00 ET	American Cyanamid, AgriPro and United Grain Growers Sign Research and Commercialization Agreement to Produce Herbicide Tolerant Wheat
Oct 20, 98
08:51 ET	American Home Products Corporation Reports Sales and Earnings for the 1998 Third Quarter and First Nine Months
Oct 13, 98
10:12 ET	American Home Products Corporation and Monsanto Company Announce Termination of Merger Agreement
Sep 24, 98
12:30 ET	American Home Products Announces Record Dividend
Sep 09, 98
14:36 ET	Study Shows No Significant Increase in Valve Abnormalities In Patients Taking Redux
Sep 08, 98
18:08 ET	American Home Products Corporation Selected as One of Working Mother Magazine's '100 Best Companies for Working Mothers'
Aug 18, 98
16:00 ET	Postmenopausal Hormone Therapy Does Not Decrease Risk of Heart Attack And Coronary Death in Women With Previous Heart Disease
Jul 23, 98
11:59 ET	American Home Products Corporation Declares Common Stock Dividend
11:59 ET	American Home Products Corporation Declares Preferred Stock Dividend
08:38 ET	Wyeth-Ayerst Files Citizen Petition For Cordarone Cites Inadequate Bioequivalence Studies
Jul 21, 98
08:09 ET	American Home Products Corporation Reports Sales and Earnings for the 1998 Second Quarter and First Half
Jun 22, 98
12:01 ET	DURACT(R) Voluntarily Withdrawn
Jun 01, 98
20:37 ET	Monsanto and American Home Products Clarify Press Reports On the Plan to Combine the Two Companies
06:48 ET	American Home Products and Monsanto Announce Plan to Combine To Create $96 Billion Life Sciences Company
May 21, 98
14:29 ET	American Home Products Corporation Declares Preferred Stock Dividend
Apr 27, 98
15:44 ET	Experts Develop New Paradigm for the Treatment of Antibiotic-Resistant Infections
Apr 23, 98
13:01 ET	American Home Products Corporation Annual Meeting of Stockholders and Declaration of Common Stock Dividend
Apr 21, 98
08:53 ET	American Home Products Corporation Reports Sales and Earnings for the 1998 First Quarter
Mar 09, 98
14:18 ET	Wyeth-Ayerst Laboratories Announces New, Convenient Delivery System for ZOSYN(R) Granted Marketing Clearance by the FDA
Mar 05, 98
13:13 ET	American Home Products Corporation Announces Organizational Changes in its Research Operations;
12:54 ET	American Home Products Corporation Announces the Appointment Of Bruce I. Macphail to Chief Operating Officer, Whitehall International Inc.
11:30 ET	American Home Products Corporation's Board of Directors Approves Common Stock Split and Declares Preferred Stock Dividend
Mar 03, 98
16:48 ET	Wyeth-Ayerst Announces Withdrawal of Verdia NDA
Feb 24, 98
13:01 ET	Wyeth-Ayerst Laboratories Announces NDA Filing For Sonata(TM) (Zaleplon) For The Treatment of Insomnia
Feb 04, 98
11:00 ET	New 500 mg Tablet of Lodine(R) XL Receives FDA Clearance
Jan 29, 98
13:24 ET	American Home Products Corporation Declares Common Stock Dividend
Jan 27, 98
16:57 ET	FDA Advisory Panel Recommends Approval of Verdia A New Therapy in the Treatment of Hypertension
08:27 ET	American Home Products Corporation Reports Sales and Earnings for the 1997 Fourth Quarter and Full Year
Jan 20, 98
08:15 ET	American Home Products Corporation Confirms Discussions With SmithKline Beecham
Dec 22, 97
09:05 ET	American Home Products Corporation Announces the Sale of Its Sherwood-Davis & Geck Business to Tyco International
Nov 25, 97
17:47 ET	American Home Products Corporation Media Statement
Nov 20, 97
19:07 ET	Premarin(R) (Conjugated Estrogens Tablets, USP) Position in Osteoporosis Reaffirmed
12:39 ET	American Home Products Corporation Declares Preferred Stock Dividend
Oct 22, 97
09:03 ET	American Home Products Corporation Announces the Sale of its Storz Instrument Company to Bausch & Lomb
Oct 21, 97
10:28 ET	American Home Products Corporation Reports Sales and Earnings for the 1997 Third Quarter and First Nine Months
Sep 25, 97
15:47 ET	American Home Products Announces Record Dividend
15:46 ET	American Home Products Corporation Announces Executive Promotions and Organizational Changes
Sep 15, 97
10:44 ET	Voluntary Recall of Pondimin and Redux to Impact Earnings for 1997 and 1998
Aug 14, 97
09:19 ET	American Home Products Corporation, Through its Subsidiary, Genetics Institute, Purchases Pharmacia & Upjohn's Recombinant Factor VIII Product
Jul 31, 97
14:02 ET	American Home Products Corporation Declares Preferred Stock Dividend
13:59 ET	American Home Products Corporation Declares Common Stock Dividend
Jul 24, 97
16:16 ET	FDA Advisory Committee Unanimously Recommends Approval of American Home Products Subsidiary, Genetics Institute's Growth Factor for Cancer Patients with Platelet Deficiency
Jul 22, 97
09:36 ET	American Home Products Corporation Reports Sales and Earnings for the 1997 Second Quarter and First Half
Jul 10, 97
17:04 ET	Wyeth-Ayerst Responds to Filing of Obesity Drugs Class Action
09:02 ET	Now Available From ESI Lederle Pentoxifylline Extended-Release 400 mg Tablets
Jul 08, 97
17:15 ET	American Home Products Corporation Responds to the Decision Against American Cyanamid
May 27, 97
16:34 ET	American Home Products Corporation Names William A. Hawkins President of Sherwood - Davis & Geck; David Low to Retire
May 22, 97
14:26 ET	American Home Products Corporation Declares Preferred Stock Dividend
Apr 28, 97
16:50 ET	American Home Products Corporation Annual Meeting of Stockholders and Declaration of Common Stock Dividend
Apr 24, 97
15:56 ET	New From ESI Lederle - Acyclovir 400 mg & 800 mg Tablets
15:55 ET	ESI Lederle Introduces Acyclovir 200 mg Capsules
Apr 22, 97
09:57 ET	American Home Products Corporation Reports Sales and Earnings for the 1997 First Quarter
Apr 21, 97
14:56 ET	American Home Products Corporation Names William A. Hawkins Vice President, Medical Device and Specialty Pharmaceutical Divisions
Apr 10, 97
06:28 ET	Agreement Between Wyeth-Ayerst Laboratories And Elan Pharmaceutical Will Expand Treatment Options for Americans Suffering from Arthritis Pain
Apr 01, 97
09:17 ET	American Cyanamid, a Subsidiary of American Home Products Corporation, Obtains EPA Registration for Lightning Herbicide
Mar 20, 97
12:37 ET	Lederle Files With FDA, Seeking Licensure for Use of Combination DTAP-Hib Vaccine in Children
Mar 18, 97
09:35 ET	Kenneth J. Martin Named President of Whitehall-Robins Healthcare
09:33 ET	American Home Products Announces Organizational Changes at Its Wyeth-Ayerst Division
08:01 ET	Wyeth-Ayerst Acquires International Rights to Commercialize New Oncology Product
Feb 26, 97
14:14 ET	American Home Products Corporation Declares Preferred Stock Dividend
Feb 06, 97
13:12 ET	American Home Products Corporation Declares Common Stock Dividend
Jan 29, 97
10:42 ET	American Home Products Corporation Announces the Retirement Of Stanley F. Barshay as Senior Vice President
Jan 28, 97
09:14 ET	American Home Products Corporation Reports Sales and Earnings for the 1996 Fourth Quarter and Full Year
Dec 17, 96
17:21 ET	American Home Products Corporation Acquires Genetics Institute, Broadening Research Opportunities in Biotechnology
Dec 16, 96
11:31 ET	American Home Products Corporation Announces Executive Appointments
Nov 21, 96
14:21 ET	American Home Products Corporation Declares Preferred Stock Dividend
Oct 22, 96
09:51 ET	American Home Products Corporation Reports Sales And Earnings For The 1996 Third Quarter And First Nine Months
Oct 07, 96
10:41 ET	American Home Products Announces Record Dividend
10:39 ET	Ivan Seidenberg Elected To American Home Products Board Of Directors
Sep 20, 96
09:07 ET	American Home Products Corporation to Acquire the World-Wide Animal Health Business From Solvay S.A.
Sep 06, 96
09:25 ET	American Home Products Corporation Announces The Sale Of Its American Home Food Products Business To Hicks, Muse, Tate & Furst
Jul 25, 96
14:04 ET	AMERICAN HOME PRODUCTS CORPORATION DECLARES COMMON STOCK DIVIDEND
13:40 ET	AMERICAN HOME PRODUCTS CORPORATION DECLARES PREFERRED STOCK DIVIDEND
Jul 23, 96
09:16 ET	AMERICAN HOME PRODUCTS CORPORATION REPORTS SALES AND EARNINGS FOR THE SECOND QUARTER AND FIRST HALF OF 1996